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Scope of the thesis
The cytoskeleton is composed of intermediate filaments, the actin network and microtubules 
(MTs); it is a dynamic cellular web that serves multiple purposes which go beyond a mere 
structural function. The cytoskeleton allows complex morphological changes in cells, which 
are critical for cell specialization and functions. This thesis describes how MT behavior can 
be influenced by subtle changes in its building block, the tubulin protein, and by a subset of 
MT-associated proteins (the so-called “+end-tracking proteins”, or +TIPs), which associate 
to the dynamic, fast-growing ends of MTs. The studies presented in this thesis widen our 
knowledge on MTs, tubulin and +TIPs. Three major issues are discussed: 1) the discovery 
of novel tubulin-associated proteins (TAPs) as well as the effects of some tubulin mutations 
involved in neurodevelopmental disorders on the MT network stability in cells and on TAP 
binding; 2) the effects of these same mutations on tubulin structure within a protofilament, 
investigated in silico with molecular modelling and molecular dynamics simulations; 3) the 
regulation of MTs by +TIPs, in particular the cytoplasmic linker proteins (CLIPs). 
Chapter 1 provides an overview of MT function, structure and behavior, together with the 
structural features, isotypes and post-translational modifications of its building block, the 
tubulin dimer. Since regulation of MTs is carried out by +TIPs, a description of the structure 
and role of the main ones presented in this thesis is also provided. Finally, a brief introduction 
to molecular dynamics simulations is given to guide the reading of Chapter 3.
Chapter 2 describes our strategy and studies centered on the identification of novel TAPs 
via purification of isotypes of α- and β-tubulin. We also report on the binding of TAPs to two 
tubulin mutants found in patients with neurodevelopmental disorders, and the effects of these 
mutations on the MT network in cells.
Chapter 3 describes the effects of the tubulin mutations (discussed in Chapter 2) on tubulin 
and protofilament structure at the atomic level, by using molecular modelling and molecular 
dynamics simulations. The model proposed helps in understanding possible mechanisms 
leading to tubulin/MT dysfunction in cells (Chapter 2).
Chapter 4 focuses on the roles in MT dynamics of the +TIP CLIP-115 compared to those of 
its close relative CLIP-170. These two proteins have always been considered redundant in 
function, but our studies suggest that they also have distinct properties.
Finally, Chapter 5 discusses the major findings presented in the other chapters, and some 
aspects of current methodologies commonly used in the field, such as in vitro reconstitution 
assays; the implications of the studies presented in this thesis and future prospects are 
addressed.

Chapter 1
General Introduction
2 
 
3Chapter 1
Microtubules
The cytoskeleton and its functions
The cytoskeleton plays a crucial role in structural stability, motility, intracellular transport and 
cellular division in all eukaryotic cells [1]. It is represented by three types of network, i.e. 
intermediate filaments (IFs), actin filaments and microtubules (MTs) (for review, see [2]). 
Briefly, IFs are non-polar structures mainly responsible for mechanical support; motor proteins 
cannot associate or move along IFs given the lack in polarity [3]. By contrast, the actin and MT 
networks are polar structures and support cell shape and intracellular transport. One of the 
major functions of the actin cytoskeleton is to induce changes at the plasma cell membrane 
by constituting, for example, filopodia [4] and lamellipodia [5,6]. Actin achieves this by exerting 
pushing and pulling forces but also by employing actin-based motors, called myosins [3,7–9]. 
MTs, the subject of this PhD thesis, are hollow tubes made up of tubulin subunits. MTs are 
important for cell shape and mitosis, and play a critical role in regulating cell polarity [10] and 
organizing the cytoplasm [11,12]. 
 MTs are also involved in various other processes, including the directional movement 
of cells [13–15]. MTs direct long-range transport of organelles in cells [15], by serving as 
“cellular railways” over which organelles and vesicles can be transported by MT-based motor 
proteins, such as kinesins [16–18] and cytoplasmic dynein [19]. Transport mediated by the 
cytoskeleton achieves displacement of organelles, vesicles, proteins, and chromosomes 
during cell division, in a much more efficient and specific manner than diffusion. Since MTs are 
essential for long-range intracellular trafficking, they are of critical value for highly polarized and 
elongated cells such as neurons. The spatio-temporal organization of the three cytoskeletal 
networks (i.e., actin and intermediate filaments, and MTs) their regulation by proteins that 
interact with them (e.g. MT-associated proteins, or MAPs), and the prompt responses, in 
particular of the actin and MT cytoskeletons, to external cues and mechanic stimuli, together 
with their cross-signaling [20,21], are of paramount importance for the proper functioning of all 
cells in our body. 
Tubulin
Tubulin structure 
MTs are dynamic hollow tubes made of αβ tubulin heterodimers stacked longitudinally into 
protofilaments, thirteen of which form a MT through lateral interactions. This description of the 
MT network is started by describing its building block: the tubulin heterodimer. Tubulin was 
first discovered by Weisenberg, Borisy and Taylor in 1968 as a “colchicine-binding protein of 
mammalian brain” [22]. The 8 nm-long tubulin heterodimer consists of two polypeptides of 55 
kDa each, α- and β-tubulin, each capable of binding the nucleotide guanosine 5’-triphosphate 
(GTP) (Figure 1). The nucleotide-binding pocket of α-tubulin, located at the interface between 
α- and β-tubulin, is called the N-site. Here, GTP  cannot be exchanged or hydrolyzed, and this 
GTP plays a structural role [23]. By contrast, GTP at the β-tubulin E-site can be hydrolyzed; 
this site can also bind guanosine 5’-diphosphate (GDP), resulting from GTP hydrolysis after 
MT polymerization [24], and exchange it again for GTP once the dimer returns to the pool of 
soluble tubulin after MT depolymerization [25]. The 40% sequence identity in their primary 
structure [26,27]  leads to a nearly identical tertiary structure for α- and β-tubulin, each 
monomer being composed by two β-sheets surrounded by twelve α-helices [25,28]. In both 
α- and β-tubulin, the N-terminal domain contains a Rossmann fold, important for the binding of 
GTP, with the signature Gly-Gly-Gly-Thr-Gly-Ser-Gly [29]. The nucleotide is further stabilized 
by hydrogen bonding with the residues Asn206 and Asn228 (Figure 1, top right). In particular, 
4this specificity is obtained by hydrogen bonding of the 2-exocyclic amino group in GTP to 
the hydroxyl groups of Asn206 and Asn228, and by hydrogen bonding of the 6-oxo group of 
GTP to the amino group of Asn-206 (see Figure 1A, top right) [25]. The intermediate domain 
comprises the strands S7–S10 and the helices H9–10 (Figure 1, bottom left) [30]. In β-tubulin, 
this domain contains a binding site for taxol, a MT-stabilizing drug (depicted as green stick 
model in Figure 1). This site is represented by a pocket facing the MT lumen in proximity to 
the so-called M-loop, which is involved in lateral interactions with the adjacent protofilament. 
In α-tubulin, the corresponding space is occupied by an eight-residue insertion in the loop 
between β strands S9 and S10 (Figure 1, bottom left) [31], hindering  the binding of the drug. 
Finally,  the C-terminal helices (H11 and H12) are a major site for the binding of MAPs (Figure 
1, bottom left) [28,32]. 
 The stability of the tubulin heterodimer relies also on its non-covalent bonds, mainly 
longitudinal hydrogen bonds at the inter-monomer interface [33]. In concert with these bonds, 
further stabilization is accomplished by a Mg2+ ion  [23] coordinating the surrounding residues 
and the GTP accommodated at the N-site (Figure 1, bottom right).
Tubulin C-terminal tails
The disordered projections that arise from the heterodimer at the C-terminal domain are 
commonly known as the tubulin “tails”. Although unstructured elements, they are highly 
important. For example, the tails are subjected to a number of post-translational modifications 
(PTMs, see section 1.3) that modify the properties of tubulin itself or of the affinity of MAPs 
for MTs [34]. The C-terminal residues of α- and β-tubulin (starting with Ser439 in α-tubulin and 
Ala430 in β-tubulin) are mainly represented by glutamate (hence the name E-hooks), and 
(together with aspartate residues) these greatly contribute to the acidic character of the tubulin 
tails and to their disordered structure [35].
 The structures of each of the tubulin tails has not been solved experimentally, but 
can be modeled as part of the tubulin (Figure 1). This is due to their flexibility and intrinsic 
disordered status, resulting in a number of possible distinct conformations that are averaged 
out during the reconstruction process of X-ray crystallography or cryo-electron microscopy 
(cryo-EM). Alternatively, it has been proposed that the heterogeneity of tubulin forms present 
in brain tissue, which is the main source of tubulin used for most studies, could lead to the 
loss of structural information. This could be caused by the differences in conformation of 
isotype-specific tails, but also by PTMs (see Post-translational modifications of tubulin later in 
this section) [34]. It is interesting to note the functional role of the aforementioned structural 
disorder. As reviewed by Roll-Mecak [34], the flexibility of the tails and their high radius of 
gyration would result in an increased probability of fruitful interactions with binding partners, 
increasing in turn the association rate. At the same time, their intrinsically disordered structure 
would also increase the “off” rate, since part of the interface would dissociate. Since the 
structural ordering of a disordered region upon binding is an energetically-unfavorable process, 
the net result is that the flexible, disordered tails would engage in highly specific, but weak 
interactions with their binding partners [36]. This is in line with experimental observations, 
since many MT-MAP affinities have been shown to be in the µM range [34].
 An interesting, recent study used NMR to investigate the tubulin tails. Although they 
were found to be disordered they did have a propensity for β-sheet conformation [37], in 
contrast with the α-helix conformations predicted by molecular dynamics (MD) simulations 
(see the dedicated section later in this chapter) [38,39]. However, in both experimental and 
in silico investigations, the tails were found to interact with the heterodimer body. Specifically, 
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in MD simulations α-tubulin tails mainly interacted with the helix H11 of β-tubulin, and 
β-tubulin tails with the respective helix in α-tubulin. Alternating interactions of α-tubulin’s H10/
B9 loop between the C-terminal tail of α-tubulin and the H11 helix of β-tubulin caused more 
fluctuations within the intermediate domain. This would mean that the C-terminal tails could 
alter the conformation of the heterodimer, thus possibly influencing assembly properties (in 
disagreement, however, with more recent studies, see next paragraph) and MAP binding [39].
Tubulin superfamily and tubulin isotypes
Different tubulin genes, belonging to the so-called “tubulin superfamily”, code for α- and 
β-tubulins, but also for γ- (gamma), δ- (delta), ε- (epsilon), ζ- (zeta), η- (eta), ι- (iota) and 
κ- (kappa) tubulins [40]. Furthermore, several tubulin isoforms, commonly referred to as 
“isotypes”, are expressed in most eukaryotes [41]. Humans have at least seven α- and eight 
β-tubulin isotypes [42], and two γ-tubulin forms. These three tubulins are synthesized in every 
eukaryotic organism investigated so far. By contrast, the genes encoding the various tubulin 
isotypes have different tissue and temporal expression patterns, suggesting that they could 
confer specific characteristics to the MTs they constitute [43–46], leading to the “multi-tubulin 
hypothesis” [42,47]. However, the different isotypes do not form distinct isotype-specific pools 
of MTs, but they can all co-polymerize into the same MT, forming a heterogeneous pool of MTs 
with different isotypes [46,48]. 
 Studies with tubulin isolated from bovine brain showed that tubulin heterodimers with 
different β isotype composition have distinct dynamic instability parameters. Specifically, MTs 
with a higher βII/βIII isotype ratio were less dynamic than when βIII was more abundant [49,50]. 
Importantly, it was recently shown what confers different isotype-specific properties to dynamic 
instability parameters and polymerization in MTs reconstituted in vitro. The residues within the 
conserved β-tubulin core are the determinants conferring the different MT dynamics behavior, 
rather than those of the C-terminal tail [51], which is instead mainly involved in interactions 
with MAPs. Most of the isotype sequence differences are located in approximately 25 residues 
of the tails, which are susceptible of many PTMs that can modulate these interactions [52,53]. 
 Gamma (γ)-tubulin is present mainly in MT-organizing centers (MTOCs) and, together 
with other proteins of the γ-Tubulin Ring Complex (γ-TuRC) (for MT nucleation structures 
described here, see Microtubule nucleation and nucleation centers in cells later in this 
section),  is involved in MT nucleation [54–56] (Figure 2) . In 2008, an interesting functional 
adaptation was found for γ tubulin. Two isoforms of γ-tubulin (γ-T1 and γ-T2) were discovered 
in the Antarctic ciliate Euplotes focardii. Comparison of the three-dimensional structures of 
the γ-tubulin of the congeneric species of temperate climates revealed differences at specific 
residues in their primary structure. In particular, these were located in regions involved in 
inter-dimer longitudinal and lateral contacts (M-loop) and in the T3 loop (Figure 1, bottom left), 
responsible for GTP binding. These adaptations are most likely to promote the nucleation of 
MTs at low temperatures. Moreover, a different cellular localization of the two isoforms was 
observed, with the γ-T1 being present in basal bodies and γ-T2 in the centrosomes of the 
micronuclear spindles [57]. These observations suggest that not only subtle residue changes 
can greatly influence tubulin behavior and stability properties, but also that different isoforms 
can contribute to different functions. 
 There is still little known about δ- and ε-tubulin. They were both identified in the 
human genome by sequence similarity to other tubulins [58], the former specifically by 
similarity to its homologue in Chlamydomonas [59]. Both are conserved in vertebrates 
and are not incorporated into MTs. Rather, they localize to the centrosome, as found by 
6immunofl uorescence experiments in human osteogenic sarcoma cells (U2OS cells). However, 
δ-tubulin was found between centrioles, suggesting a role in centriole bridging, for Paintrand 
and co-workers observed fi bers linking the two centrioles [60], or centriole separation. In fact, 
the pattern of localization resembles that of Skp1, a component of the SCF ubiquitin ligase, 
which is required for centriole separation [61].
Asn228
Asn206
Thr145
Ser147
E-site
N-site"tails"
M-loop
Mg2+
T3 loop
Taxol
S7
S7
S10
S10
H9
H9H10
H10
H12
H12
H11
H11
Figure 1. Full model of the tubulin heterodimer. Bottom left, tubulin structure modelled based on the structure depos-
ited by Nogales et al. (Löwe et al. 2001) with PDB entry 1JFF. Red: β-tubulin, blue: α-tubulin. The deposited structure 
was modifi ed as follows. The Zn2+ ion was removed; the GDP at the E-site was substituted by GTP and Mg2+ using 
the translated coordinates of the GTP and Mg2+ at the N-site. The α-tubulin N-terminal loop (residues 35 to 60) was 
reconstructed by homology with the corresponding β-tubulin loop. The secondary structure elements cited in the text 
are marked accordingly (“H”: α-helix; “S”: β-strand). The C-terminal tails were modelled ab initio using the software 
Modeller (Webb and Sali 2014); the C-terminal α-tubulin tyrosine residue is depicted as sticks. The taxol molecule 
is depicted in green behind the M-loop. The residue signature Gly-Gly-Gly-Thr-Ser-Gly is represented in cyan; the 
residues threonine and serine are depicted as sticks. Top left, top view of the heterodimer, looking towards the E-site. 
Top right, close-up view of the area enclosed by the dashed circle with the residues Thr145, Ser147, Asn206 and 
Asn228 depicted as sticks.  Bottom right, close-up view of the N-site (dashed circle) highlighting the residues within 
4 Å of the  GTP or Mg2+ ion colored by chain (same color-code as in the model). Figure generated with Chimera 
(Pettersen et al. 2004).
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 Epsilon (ε)-tubulin localizes to the pericentriolar material of the centrosome during and 
after mitosis. This tubulin isotype might be involved in the regulation of a cell-cycle-specifi c 
function, such as centrosome duplication, or cell-cycle-specifi c recruitment of other molecules 
to the centrosome [62].
 Zeta (ζ)-tubulin is the last tubulin characterized in vertebrates. A recent study by Turk 
and co-workers suggested a conserved pattern: fi rst, organisms lacking ε-tubulin always also 
lack δ- and ζ- tubulins; second, the presence of ε-tubulin is always accompanied by that of δ- 
and/or ζ-tubulin. Therefore, ζ-tubulin, together with δ- and ε- tubulins, has been classifi ed as 
a member of the so-called ZED tubulin module [63]. Zeta (ζ)- and δ- tubulin are evolutionarily 
interchangeable: in humans ζ-tubulin is not produced, in contrast to δ-tubulin. In Xenopus 
multiciliated cells, ζ-tubulin is a component of the basal foot, a centriolar appendage that 
connects centrioles to the apical cytoskeleton, and co-localizes there with ε-tubulin. It has been 
proposed that ZED tubulins are important for centriole functionalization and for orientation of 
centrioles with respect to cellular polarity axes [63].
 Eta (η)-tubulin was fi rst identifi ed by genetic screening in Paramecium [64]. It has been 
suggested that the function of η-tubulin might be to tether γ-tubulin-containing complexes to 
the sites of basal body duplication (since γ-tubulin is required for this function [65]), where it 
might either stabilize nascent MTs in developing basal bodies or transduce a signal for basal 
body duplication [66].
 Finally, genomic sequences for ι-, κ-, and θ-tubulin from Paramecium species have 
been reported in databases, but their cellular functions are still unknown.
Post-translational modifi cations of tubulin
Tubulin can be post-translationally modifi ed, and this occurs mainly at its tails. The main 
PTMs include detyrosination (Arce et al. 1975; Barra, Arce, and Argaraña 1988), glutamylation 
[69,70], acetylation [71], methylation [72] and glycylation [73], and these will be described 
below. Other modifi cations (phosphorylation, polyamination, palmitoylation, ubiquitination, 
glycosylation, arginylation, sumoylation (reviewed by [74])  have also been identifi ed but have 
not been  investigated in detail. 
MTs
γ-TuRC
centrioles
Figure 2. Centrosomal and non-centrosomal MT nucleation. Simplifi ed and schematic representation of an animal cell 
highlighting the organization of MTs (green lines) nucleating from a centrosome (inset) or the trans-Golgi apparatus 
(pink stacks surrounding the nucleus, in purple). Inset: the yellow shaded area is the pericentriolar material, the 
perpendicular elements the pair of centrioles and the green dashed circles the γ-TuRC as indicated by the arrows.
8 The major PTMs occur after the dimers have been incorporated into MTs [75], 
which could explain the observation that taxol-induced stable MTs often accumulate more 
of these modifications than dynamic ones [76–79]. In fact, since incorporated tubulin dimers 
are retained for much longer times in stable MTs than those of dynamic MTs, they have an 
increased likelihood of acquiring  PTMs. PTMs can influence MAP binding and, indirectly, MT 
dynamics and stability, and are therefore critical to MT function [80]. 
Detyrosination
This PTM occurs only on α-tubulin. Detyrosination was the first MT-associated PTM to be 
discovered, about 40 years ago [81]. The last C-terminal residue of the α-tubulin isotypes, 
except for TUBA4A and TUBA8, is tyrosine, which can be removed specifically by an unidentified 
tubulin carboxypeptidase once α-tubulin is incorporated into MTs [76,82]. Little is known 
about this process. An increased level of detyrosination is observed on stable MTs, as their 
prolonged lifetime allows them to acquire the PTM in ever increasing quantities. It is unclear 
whether detyrosination induces per se the formation of stable MTs; however, experiments in 
Vero cells showed that detyrosinated MTs were more resistant to depolymerization at higher 
concentrations of nocodazole (a MT-depolymerizing compound) than tyrosinated MTs [83]. 
Detyrosination has also been shown to protect MTs from kinesin-2 mediated depolymerization 
[84]. 
 Importantly, de-tyrosinated tubulin can be tyrosinated again by the enzyme tubulin 
tyrosine ligase (TTL). This enzyme is able to recognize the three-dimensional structure of the 
curved tubulin dimer in the cytoplasm and to perform the ligation reaction [85]; this reaction 
does not occur when the tubulin dimer is within the MT; TTL even prevents its incorporation 
by capping the dimer longitudinally [75,85]. Loss of TTL results in morphological abnormalities 
and it is involved in cancer [75]. Interestingly, studies in Madin-Darby Canine Kidney (MDCK) 
epithelial cells showed that the level of MT detyrosination increased as the cells approached 
confluency, and then decreased when the cells became polarized at confluency  [86,87].
 An example of functional co-existence of these PTMs is given by neurons, where 
immunoelectron microscopy studies with an antibody against tyrosinated tubulin showed that 
axonal MTs are dynamic (and tyrosinated) at the +end of the more stable, non-tyrosinated 
MTs [88,89]. This was later confirmed at a higher resolution on individual MTs [90]. These 
observations suggest that axonal MTs are composed by a more recently-assembled domain 
(tyrosinated tubulin-rich) extending from a stable domain (tyrosinated tubulin-poor) (Figure 3). 
Also, tyrosinated tubulin was prevalently found in growth cones [90,91]. As for the functional 
role of tubulin tyrosination, a Ttl-null mouse model showed that the lack of TTL leads to 
abnormal neuronal morphology and respiratory problems and is lethal within 1 day after birth 
[92]. Therefore, tubulin tyrosination and detyrosination are essential events that need to occur 
in MTs in a specific and regulated manner.
∆2- /∆3-modifications
Detyrosinated α-tubulin can undergo removal of another residue, i.e. the ultimate glutamate 
[93]. This deglutamylation is carried out by one of six specific cytosolic carboxypeptidases 
(CCPs) (CCP1 [94], CCP2/3 [95], CCP5 [96], and CCP4/6 [97]). Remarkably, the newly-
exposed glutamate residue cannot be tyrosinated; ∆2-α-tubulin is mostly found in stable MTs 
and is enriched in neurons, centrioles and cilia [98,99]. Although this modification is highly 
present in brain MTs [99], its exact function has not yet been elucidated. 
 Recently, another modification of the α-tubulin terminus has been identified in rat 
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brain tissue. It consists of the removal of the ultimate glutamate residue produced after the 
aforementioned ∆2-modifi cation process, and is therefore named ∆3-modifi cation [100]. All 
the CCPs cited above, except for CCP2 and CCP3, are able to remove the ultimate glutamate 
on ∆2-tubulin. Discrepancies have been observed for CCP5, which appears to act only on the 
isotype α4A and not on α1B tubulin –when fused to mCherry- (see [96] and [100]). ∆3-tubulin 
appears to have similarities with tyrosinated tubulin, in that they were both recovered to a 
larger extent in the soluble fraction (44% and 30%, respectively) rather than in the microtubular 
fraction after treatment with nocodazole and high-speed centrifugation, perhaps indicating 
that the ∆3-modifi cation could be associated to only mildly stable MTs. This was in contrast 
to the behavior of detyrosinated tubulin, which is recovered predominantly in the microtubular 
fraction (96%). In the same study ∆4-β-tubulin (lacking the last four residues) was also 
identifi ed, raising the question whether more PTMs with further trimming of the tubulin tail are 
still to be found.
 The only example of β-truncation in mammals is reported by Miller and co-workers 
[101], who demonstrated the removal of the C-terminal alanine and the penultimate valine 
residues from the β2-tubulin isotype in rat liver tissue. As for ∆2, the functions of all of these 
PTMs need to be elucidated.
Acetylation
Discovered about 30 years ago [71,78], this PTM occurs at the residue lysine 40 (Lys40 or K40) 
of α-tubulin [102]. Since K40 is located on a loop facing the lumen of the MT, the enzyme has 
to reach the inside of the MT tube to perform its activity, in contrast to modifi cations occurring 
+
+
+
+
+
+
+
+ +
+
- -
-
- -
--
-
-
-
-
-
+
+
+
+
-
+-
acetylated α-tubulin
detyrosinated α-tubulin
tyrosinated α-tubulin
stable dynamic
Figure 3. PTMs in neurons. Simplifi ed and schematic representation of a neuron, highlighting the stable and dynamic 
segments of MTs, together with their polarity (+: +end, -: -end).  Axonal MT bundles possess a homogeneous distal 
+end polarity, in contrast to MTs in dendrites. The inset shows the most abundant PTMs present on an axonal MT: the 
dynamic portion is enriched in tyrosinated α-tubulin, whereas the older, stable segment is abundant in detyrosinated 
and acetylated α-tubulin.
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at the C-terminal tails. The transfer of the acetyl moiety from acetyl-CoA to Lys40 is catalyzed 
specifically by the enzyme tubulin acetyltransferase 1 (TAT1, also known as MEC-17) [103]. 
Using a combination of in vitro experiments and computer simulations, it was recently shown 
that TAT1 enters the lumen of the MT either from the –preferentially tapered- ends, where the 
enzyme concentrates, or through transient bends and breaks in the MT lattice [104]. These 
results are in contrast to the model proposed by Shida and co-workers, according to which 
the entry of TAT1 would be allowed by regular MT lattice breathing [105].  Alterations in MT 
structure could modulate the affinity of TAT1 for its binding sites, determining the extent of 
acetylation. The slow diffusion of TAT1 within the MT lumen would explain the acetylation 
patches observed in stable MTs in cells [78,106,107]. In fact, the long lifetimes of stable MTs 
increase the probability of lattice defects, leading to an increased TAT1 accumulation and 
thus, a higher degree of acetylation. Acetylated MTs are enriched in cilia and flagella; loss of 
TAT1 is associated with defective axonal morphology and neurodegeneration in the nematode 
worm Caenorhabditis Elegans [108,109] and, although viable, Tat1 knockout mice showed 
sperm defects [110]. Acetylation is associated with MT stability, although it does not appear 
to act directly on MT structure [111], and experiments showed that this modification did not 
influence MT dynamics [112]. However, in vitro experiments showed that a decreased level of 
MT acetylation causes reduced binding and motility of the molecular motor kinesin-1 on the 
MT [113]. Increased MT acetylation, conversely, promoted dynein and kinesin-1 recruitment 
[114]. Thus, the extent of MT acetylation has to be finely regulated by the cell to ensure proper 
levels of binding and motility of these motor proteins.
 Acetylation of α-tubulin is reversible. While acetylation occurs in MTs, deacetylation 
of K40 of α-tubulin occurs on free tubulin dimers [115] and is performed by the histone 
deacetylase 6 (HDAC6) [116] (for a brief overview on histones, see section “Methylation”) 
or by the non-classical HDAC (sirtuin) SIRT2 [117]. Both enzymes have several other target 
proteins; strikingly, Sirt2 knockout and Sirt2/Hdac6 double knockout mice are viable and 
normal [118]. Interestingly, no change in α-tubulin acetylation was observed in Sirt2 knock-
out cells, whereas cells from Hdac6 knock-out mice showed an increased MT acetylation 
compared to wild-type controls, but still without producing any remarkable phenotype [119]. 
The main effects regarded behavior, since Hdac6 knock-out mice were hyperactive, less 
anxious and with a lower depression tendency than wild-type mice [120]. HDAC6 could also 
play a role in inflammation, as MT acetylation would result in an increased production of the 
anti-inflammatory interleukin (IL) IL-10 [121]. Taken together, these studies suggest a pivotal 
role played by HDAC6 rather than by SIRT2 in MT deacetylation. However, the exact function 
of acetylation on MTs remains elusive (for a comprehensive review, see [122] ).
Glutamylation 
Glutamylation consists of the addition of one or more glutamate residues (poly-glutamate 
chains) to the tail of α- or β-tubulin. It occurs through the formation of peptide bonds branching 
off the γ-carboxyl groups of the existing glutamates [69]. This PTM is catalyzed by enzymes 
called glutamylases, nine of which have been identified in mammals [123]. They have different 
preferences for the tubulin subunit they act upon, and also with different abilities in starting 
or extending the glutamylation process [124]. These enzymes belong to the TTL-like (TTLL) 
family, as they contain a TTL-homology domain that allows ligation of different amino acids 
to tubulin [123,125]. It has been shown that the number of added glutamate residues ranges 
from 1 to 6 and the position of the PTM depends on tubulin subunit and isotype: at Glu445 
in the tubulin isotypes α1 and α2 [69], Glu443/445 in α4 [126], Glu438 in β6 [127], Glu435 in 
β2 and β3 [70,128,129], Glu434 in β4 and Glu441 in β5 [130]. Interestingly, the abundance 
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of glutamylated β-tubulin and the extent of this modification was found to increase during 
neuronal differentiation [131,132]. However, Wolff and colleagues, who developed the GT335 
antibody to detect glutamylated tubulin, found that α-tubulin was more glutamylated than 
β-tubulin in mouse brain, whereas only β-tubulin was glutamylated in non-nervous tissues, 
although to a lower extent than in brain [133]. In other tissues, glutamylated MTs are enriched 
in axonemes of cilia and flagella, but also in centrioles [62,129]. 
 It has been proposed that glutamylated MTs contribute to intracellular traffic and in 
the regulation of motility in cilia and flagella, by acting on the binding of the cytoplasmic and 
axonemal dynein molecular motors [134–136] (see section 2). Cellular and in vitro assays 
showed that glutamylation can also mediate MT severing. In fact, long polyglutamate chains 
(formed by TTLL6, and often abundant in brain tissue) induced a higher degree of MT severing 
by spastin  than shorter chains (added by TTLL4) [137–139]. 
 The extent of polyglutamylation has been shown to be crucial in the regulation of MAP 
binding to MTs: Tau, kinesins, MAP1B and MAP2 all show preferential binding with increasing 
affinity for mono-, di-, or triglutamylated MTs, the last modification being responsible for 
the highest relative affinity. As the glutamate chain grows further, the affinity progressively 
decreases [140–142]. An exception to this mechanism is represented by MAP1A, which 
maintains high affinity for longer polyglutamyl chains in α- and β-tubulin [142].
 The reversal of polyglutamylation (deglutamylation) is catalyzed by the CCPs 
(discussed above, section 1.3.2). However, only one of them (CCP5) preferentially removes 
the branching glutamates added by the TTLLs [97,143]. Nevertheless, similarly to the other 
CCPs, CCP5 is able to remove not only TTLL-added glutamates, but also those that are 
present in tubulin itself [96]. The neurodegeneration phenotype of the pcd (Purkinje cell 
degeneration) mouse model [144,145] was shown to be due to a mutation of the Ccp1 gene. 
Hyperglutamylation was observed in brain areas that undergo degeneration (such as the 
cerebellum and the olfactory bulb [97]). A possible explanation for the neurodegeneration 
could be the effect of polyglutamylation on MAP binding and MT severing by spastin (as 
described earlier). Nevertheless, despite the efforts made so far, it is still difficult to ascribe 
specific functional roles to MT polyglutamylation. Interestingly, survival of Purkinje cells was 
observed when Ttll1 was also knocked-out, suggesting that balancing the glutamylation level 
on MTs is crucial for neuronal survival [94,97]. 
Glycylation
This PTM consists of the addition of glycine residues to the terminal glutamate of α- or β-tubulin 
[146,147] and is abundant in cilia and flagella, the only structures where this modification 
has been found so far [148]. Similar to glutamylation, glycylating enzymes are members of 
the TTLL family described above. In mammals, TTLL3 and TTLL8 are responsible for the 
formation of a γ-linked isopeptide bond between the glycine and the terminal glutamate of 
α- or β-tubulin [146,147]. The chain can then be further extended by TTLL10, which indeed 
is an elongating glycylase [149]. However, in humans, this protein has lost its enzymatic 
activity presumably due to two amino acid changes, and thus MTs in cilia and flagella MTs are 
monoglycylated [150]. An example is represented by MTs in human sperm flagella, which are 
in fact monoglycylated. Thus, it appears that MT monoglycylation is able to sufficiently fulfill 
the functions of protein glycylation [150] and that the lack of polyglycylation does not impede 
ciliary beating [151]. 
 Interestingly, conventional knock-out mice for Ttll3 show lack of MT glycylation in the 
colon, indicating that TTLL3 is the only functional glycylase present in this tissue. Here, the 
12
lack of this PTM leads to decreased number of primary cilia and increased development of 
colon tumors [152]. The lower amount of cilia compared to wild-type mice could be explained 
by the fact that non-glycylated axonemes (see section “Microtubule nucleation and nucleation 
centers in cells”) disassemble after initial assembly, impairing normal ciliogenesis and leading 
to the phenotype [150,153]. Interestingly, development of cancer due to defective ciliogenesis 
was also observed in human breast cancers [154], indicating that misregulation of ciliogenesis 
(via lack of MT glycylation or via down-regulation of cilia-associated genes, as for the study on 
breast cancer just mentioned) is an important factor for cancer development.
Methylation
Tubulin methylation is in fact a tri-methylation (the addition of three methyl groups) event and 
occurs at Lys40 of α-tubulin. This modification was first identified in tubulin of Toxoplasma gondii 
[72], and recently new insight was gained through a study by Park et al., who discovered a 
common player in the well-known “histone code” and the more recently proposed “tubulin code” 
(see below). Briefly, histones are basic, dimeric proteins interacting with the 2’-deoxyribonucleic 
acid (DNA) [155]. Histones H2A/H2B, H3 and H4 constitute the octameric nucleosome core, 
around which 146 base pairs (bp) of DNA are wrapped [155]. Histone association compacts 
chromatin and any PTM that alters histone association can thus affect transcriptional activity. 
Indeed, certain PTMs at histone tails do regulate chromatin accessibility of the transcription 
machinery, as well as the recruitment of non-histone chromatin modifiers and transcription 
factors (TFs) according to the combination of modifications present (reviewed by [156]).  The 
“histone code” represents the combinations of PTMs at the terminal protrusions (“tails”) of 
histones [157].
 Modifications of histone and tubulin tails have always been considered to belong to 
distinct machineries. The histone methyltransferase SET-domain containing 2 (SETD2, or 
KMT3A) is involved in transcriptional elongation by performing trimethylation of lysine 36 
of the histone H3. Strikingly, SETD2 is another example of “histone-tubulin code bridge” 
(see HDAC6, discussed above). SETD2 is, in fact, a common “writer” of methylation of 
both histones and tubulin [158]. Specifically, SETD2 performs trimethylation of lysine 40 of 
α-tubulin, the same residue being also subject to acetylation, during mitosis and cytokinesis. 
Co-immunoprecipitation experiments confirmed the direct interaction between SETD2 and 
α-tubulin. Knock-out cells for this enzyme showed non-methylated MTs, anomalies in mitosis, 
cytokinesis, micronuclei and polyploidy. Interestingly, rescue experiments restored this normal 
phenotype, whereas synthesis of a SETD2 mutant protein, which was unable to perform 
methylation of α-tubulin, but not of the histone H3, failed to do so. This led to the conclusion 
that trimethylation of lysine 40 of α-tubulin, and not that of lysine 36 of histone H3, is needed 
for normal mitosis. This modification would play a role in preventing aberrant chromosome 
segregation and thus genomic instability, potentially leading to cancer [159]; in fact, mutations 
of SETD2 have been found in various types of cancer (as reviewed by [160]).
Structure and dynamic behavior of microtubules 
Structure of microtubules
As mentioned above, MTs are made of the protein tubulin, whose functional form is the α-/β-
tubulin heterodimer (Figure 1). In MTs the heterodimers stack in a head-to-tail fashion to 
constitute a protofilament [161–165];  in cells, 13 protofilaments associate laterally to ultimately 
form a hollow MT tube of approximately 25 nm in outer diameter [166,167] (Figure 4 and Figure 
5). Having a high persistence length –up to about 3 mm for tens of µm-long MTs - [168], MTs 
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are rigid filamentous structures. Early EM studies showed the existence of two possible MT 
lattice conformations: the “A-lattice”, which describes only heterotypic (α-β) inter-protofilament 
contacts, and the “B-lattice” [169]. In the latter, lateral contacts occur via adjacent α-tubulin - 
α-tubulin or β-tubulin - β-tubulin interactions (homotypic contacts). In the B-lattice, MTs show 
a helical symmetry, conferring a pitch to the tubulin subunits, represented by a rise of 3 tubulin 
monomers after one complete turn (3-start helix). This results in lateral α-β tubulin contacts 
at the “seam” [170,171], which are presumably weaker than the homotypic contacts (Figure 4 
and Figure 5). The B-lattice has been shown to be the natural-occurring lattice conformation 
[170]. In in vitro reconstitution and polymerization assays with purified tubulin, MTs are usually 
constituted by 14 protofilaments, although it has been observed that this number ranges from 
11 to 16 or even 17 [172]. Variation in the number of protofilaments has been observed even 
within the same MT [173,174], perhaps due to the flexibility of the lateral loops mediating the 
inter-protofilament interactions.
Dynamic behavior of microtubules
MTs are highly dynamic in order to quickly reorganize according to the needs of a cell. Due to 
the nature of the α-/β-heterodimer, MTs are polarized structures, and consequently their ends 
have different structural and functional characteristics. The end exposing the β-tubulin to the 
cytoplasm is termed the “ plus end” (from now on referred to as “+end”) and its polymerization 
rate is higher than the other end, called “ minus end” (from now on referred to as “ –end”), 
which exposes α-tubulin [175] (Figure 4 and Figure 5). The +end explores the cytoplasm 
and engages in interactions with other proteins, cellular structures and the cell cortex [176], 
whereas the -end is less dynamic and is usually embedded in nucleation centers [177]. 
 MTs can grow and shrink repeatedly in a process termed dynamic instability [162,178] 
and they can therefore be considered to be in a continuous “search-and-capture” process 
where the ends are constantly “exploring” the cytoplasm of cells in “search” of other structures 
(e.g. kinetochores) that can be “captured” [179,180]. Dynamic instability is regulated by GTP 
hydrolysis in β-tubulin; the transition from MT growth to shrinkage, which eventually leads to 
protofilaments curling outwards, is called catastrophe, while the transition from shrinkage to 
a growth phase is called rescue. Growth and shrinkage rates, together with catastrophe and 
rescue frequencies, represent the four basic parameters describing MT dynamic behavior. 
MT dynamics would be a stochastic process without a regulatory system. Such system is 
represented by a large variety of MAPs, among which are also the so-called MT “+end tracking 
proteins”, or +TIPs, which specifically associate with the +ends of growing MTs (see section 
2). +TIPs greatly influence MT behavior and, indeed, the +end is where much of the MT 
dynamics regulation takes place [180]. 
GTP hydrolysis and GTP cap model
A key feature needed for MT dynamics is represented by GTP hydrolysis at the inter-dimer 
interface. This interface is formed when the α-tubulin subunit of an incoming tubulin heterodimer 
establishes longitudinal contacts with the solvent-exposed E-site on the β-tubulin (bound to 
GTP) of another heterodimer, in a protofilament of the growing MT. After dimer incorporation into 
the elongating protofilament, GTP hydrolysis takes place [181], thereby leading to a MT lattice 
prevalently constituted by tubulin dimers with GDP at their E-sites, and a MT +end constituted 
by tubulin dimers still binding GTP, not yet hydrolyzed. However, studies with non-hydrolyzable 
analogues (such as guanosine-5’-[(α ,β)-methyleno]-triphosphate, or GMPCPP) suggested 
that GTP hydrolysis is not required for MT polymerization, but rather for its depolymerization 
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Figure 4. Computational reconstruction of an MT seg-
ment. 13 protofi laments interact laterally with a rise 
of 3 monomers after one complete turn (13-3 micro-
tubule). Red: β-tubulin, blue: α-tubulin. The “seam”, 
where heterotypic contacts take place, is clearly vis-
ible. The reconstruction was carried out by fi tting in 
the cryo-EM density map (EMD-5193 (Sui and Down-
ing 2010)) of a microtubule the minimized modelled 
dimer (exclusive of tails) and by performing the nec-
essary symmetry operations. Figure generated with 
Chimera (Pettersen et al. 2004).
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and for maintaining proper MT dynamics [182,183]. Also, Hyman et al. proposed that GTP 
hydrolysis could inhibit spontaneous MT nucleation, which instead occurred in the presence 
of GMPCPP [182]. Regarding the mechanical reason of depolymerization driven by GTP 
hydrolysis, Caplow et al. [184] showed that the free energy change derived from GMPCPP 
hydrolysis was almost zero in MTs, indicating that the MT lattice becomes thermodynamically 
unstable as the hydrolysis events take place within the MT. This energy, accumulated as 
strain in the lattice, is released during MT depolymerization. To counteract this energy release, 
since GTP hydrolysis occurs rapidly during polymerization, a model was proposed in which 
a stabilizing feature was present at the end of the growing MT. This “GTP cap” model [178] 
was suggested also in light of the long kinetic lag between tubulin polymerization and GTP 
hydrolysis [185]. Experimental evidence was provided by ultra-violet (UV) micro-beam cutting 
and micro-needle severing of single MTs: the new +end rapidly depolymerized, while the 
original remained intact [186,187]. Furthermore, it was proposed that a monolayer of GTP-
tubulin would be sufficient to exert this protective effect against depolymerization [188], 
although it has also been suggested that up to 200 dimers could constitute the GTP cap [189].
Microtubule nucleation and nucleation centers in cells
MT nucleation, the formation of the first part of the MT through tubulin assembly, is a 
thermodynamically unfavorable process, which is  believed to occur with at least a two-step 
mechanism [190,191]. The initial energetic barrier for tubulin polymerization and protofilament 
assembly is overcome via so-called MT nucleation-promoting complexes. In cells, this is the 
γ-tubulin ring complex (γ-TuRC), comprising γ-tubulin and γ-tubulin complex proteins (GCPs) 
[192,193]. The structure of the γ-TuRC complex is such that it can both provide the basis for 
the 13 PFs observed in cellular MTs, as well as for the B-type lattice. In vitro, MT nucleation 
occurs at pre-formed MT seeds (Note: seeds are short MTs, usually stabilized with taxol or 
GMPCPP, often used in in vitro assays as a template for MT growth). A recent study revealed 
a second energetic barrier for MT nucleation [191]. 
 Using in vitro single-molecule assays it was shown that certain MAPs can stimulate 
or inhibit the rate of MT nucleation in the presence of nucleation-promoting complexes. 
Experiments showed that there was a kinetic barrier preventing MT nucleation; in fact, no MT 
nucleation was observed in a range of tubulin concentrations (4 µM to 6 µM) above  the critical 
concentration (Cc, ca. 1.3 µM) for MT elongation, which was extrapolated from the fitting of the 
curve of growth rate in function of  tubulin concentration  (Note : in its simplest form the Cc is 
defined as Cc=koff/kon, where koff is the dissociation rate constant of tubulin subunits from the 
MT and kon the apparent association rate constant [191]). An increase in tubulin concentration 
to 15 µM resulted in nucleation of MTs from GMPCPP seeds in the absence of any MAP; 
decrease of the tubulin concentration to lower values (4 µM) was sufficient to maintain MT 
elongation after nucleation, but was insufficient to generate MTs in the absence of a growth-
promoting MAP. Furthermore, catastrophe-promoting factors like MCAK (a MT depolymerase 
[194]) and EB1 [195], delayed the onset of nucleation, whereas anti-catastrophe proteins 
(such as Tpx2) and a processive MT polymerase, XMAP215 [196,197] (chTOG in human), 
shortened the time lag before observing MT nucleation. Therefore, MT nucleation does not 
occur with tubulin alone at low protein concentrations (1.3 µM - 6 µM), despite being above the 
Cc. Instead, anti-catastrophe factors are needed to overcome this second energetic barrier, 
thus playing a pivotal role in this process.
 In cells MT nucleation occurs at MTOCs, where the MT nucleation-promoting complexes 
(i.e., γ-TuRCs) accumulate. In many cells the centrosome is the major MTOC [198,199], but 
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in differentiated animal cells (e.g. muscle cells, epithelial cells and neurons), the centrosome 
becomes inactive by losing proteins of the pericentriolar material (see below) - that re-localize 
e.g. to the cytoplasmic membrane or to the nuclear envelope - and  non-centrosomal MT 
nucleation occurs [200,201]. Besides the centrosome, also the Golgi apparatus [202–206] or 
severed MTs [207,208] can act as nucleation sites. 
 The centrosome is composed of a pair of centrioles, which attract (and are therefore 
embedded in) pericentriolar material, composed of many different proteins [209]. The pair 
of centrioles is oriented perpendicularly (Figure 2), and each centriole consists of a set of 9 
triplets of MTs organized in a cylindrical array. Centrioles have a relatively confined dimension, 
measuring about 0.5 µm in length and 0.2 µm in diameter [210]. It is unknown how this is 
regulated, but several proteins associate to centrioles to stabilize them. The protein CP110 
is a strong candidate for this function: it localizes to centriole tips and its depletion leads 
to the formation of abnormally long centrioles; the excessive length makes them prone to 
fragmentation, thus allowing MT nucleation at multiple sites, ultimately originating abnormal 
mitotic spindles [211,212]. 
 The centrioles not only organize the centrosome, being therefore required for 
chromosome segregation [200,213]; they are also necessary for ciliogenesis [200], a process 
leading to the formation of cilia and flagella, whose core, the axoneme, is made of MTs. 
Axonemes of primary (non-motile) cilia are composed of 9 MT doublets arranged radially 
[214,215]. This type of cilia is mainly involved in sensing extracellular cues and in activating the 
downstream intracellular signaling pathways [216]. Primary cilia are found, for instance, in the 
nasal cavity as olfactory sensors, and on luminal surfaces of renal tubules, biliary ducts, and 
vascular endothelial cells, as mechanosensors of fluid flow [217,218]. Axonemes of motile cilia 
and flagella are composed of 9 MT doublets surrounding two central MTs (“9+2 axonemes”) 
[215]. This type of structures are capable of performing regular beating through the action 
of the axonemal dyneins (see section “Molecular motors”), which are responsible for the 
sliding of adjacent MT doublets relative to each other [3,219]. Motile cilia and flagella allow the 
movement of fluid relative to the cell. For instance, motile cilia can be found on the ependymal 
cells lining the ventricles of the brain, to ensure cerebrospinal fluid flow by coordinated beating, 
and flagella allow sperm cell motility in a similar fashion [220]. Ciliogenesis is initiated by one 
centriole being tethered to the plasma membrane, known as basal body. This process involves 
an intricate network of several proteins playing a role in the initial docking of the basal body, 
but also in the elongation of the axoneme itself. Furthermore, cilia are dynamic structures 
that require a continuous supply of molecules for their maintenance; this is based mainly on 
transport, in which molecular motors play a pivotal role [220]. 
 As stated above, centrosomes are not essential in all cells; many animal cells do not 
have them [200] as in the flatworm Planaria, which possesses centrioles to form the cilia, but 
not centrosomes [221]. Centrosomes do not exist in higher plants either. Mammalian oocytes 
lack centrosomes, and bipolar spindles can form in the vicinity of chromosomes [222]. This is 
achieved through a pathway that involves the small GTPase Ran and the action of MT motors 
and MT-bundling proteins [223]. As an example, one of the proteins involved in MT nucleation 
at this location is the protein Tpx2 [224,225], which serves as a stabilizing factor of early MT 
nucleation intermediates to promote MT nucleation in concert with the protein chTOG [226]. 
Microtubule-associated proteins
Regulation of MT behavior is essential for the proper orchestration of cellular activities. In fact, 
while a population of MTs can be probing the cytoplasm, another can be considerably less 
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dynamic.  MTs can engage in interactions with target structures in order to re-localize them 
within the cell. MTs can perform such functions by virtue of their dynamic instability, which 
provides mechanical pushing/pulling forces during assembly or disassembly, respectively 
[227]. MTs also represent the “cellular tracks” onto which motor proteins with their cargos can 
dock and move. Several MAPs play a role in mediating and regulating these tasks. They can 
be broadly classified as structural MAPs, molecular motors, -end (“-end”) tracking proteins 
(-TIPs) and +end tracking proteins (“+ TIPs”), which specifically associate with -ends and 
+ends, respectively. +TIPs are particularly important for MT dynamic instability properties. 
Structural MAPs  
Structural MAPs, mainly found in neurons, were originally discovered by Murphy and Borisy 
in 1975 [228] as interacting factors during tubulin purification performed with repeated cycles 
of polymerization-depolymerization from brain lysates [229,230]. These  MAPs tend to be 
elongated proteins with repeated domains that allow simultaneous interactions with multiple 
tubulin dimers [231], a characteristic that could be responsible for their MT-stabilizing role. 
They associate along the MT lattice during interphase and, upon entry in mitosis, they become 
phosphorylated. A kinase responsible for mitotic entry, Cdk1, is responsible for phosphorylation 
of  β-tubulin, as well as of MAPs (such as MAP4), and molecular motors [232]. 
 Phosphorylation decreases the affinity between the MAPs and the MTs [233,234] or 
reduces their MT-stabilizing activity [235]. As another example, the family of protein kinases 
MARK phosphorylates the proteins Tau, MAP2 and MAP4; overexpression of MARKs in cells 
leads to hyper-phosphorylation of these MAPs on KXGS (lysine-any amino acid-glycine-serine) 
motifs and to disruption of the MT array, resulting in morphological changes and cell death. 
[234]. Removal of phosphate groups from these proteins is achieved through phosphoprotein 
phosphatases (PPPs) such as PPP1, PPP2 and PPP3; removal of the phosphate groups 
reverses the effects induced by phosphorylation. The finely-tuned interplay between kinases 
and phosphatases is crucial in cells, and especially in neurons, as described very recently 
[236].
 Although structural MAPs are normally associated with MT stabilization, a recent 
study [237] uncovered a new, important role for MAP1 proteins (MAP1A and MAP1S), which 
goes beyond their “classical” MT-stabilizing action. They observed that MAP1A and MAP1S 
interact with the HIV-1 capsid protein p24, mediating its trafficking towards the nucleus with 
a saltatory motion. Such behavior could involve detachment and reattachment to MTs using 
MAP1 proteins as anchor points [237]. MAP1-knockown cells showed an overall nuclear 
import defect, and an accumulation of viral capsids away from the nucleus [237]. Therefore, 
MAPs confer stabilizing properties to MTs, but they can also facilitate (at least in the case of 
MAP1A and MAP1S) HIV-1 early infection. 
 Another group of MAPs is represented by the “stable tubule only polypeptides” 
(STOPs), which confer MT resistance to cold. This effect is achieved through MT-binding 
motifs that can also simultaneously bind calmodulin, to which STOPs owe their regulation. 
Their function seems to be particularly important in neurons, since STOPs promote neuronal 
differentiation and are almost permanently associated to neuronal MTs; knock-out mice for 
these proteins displayed synaptic defects associated with neuroleptic-sensitive behavioral 
disorders, caused by a two-fold reduction in pre-synaptic vesicle density in CA1 hippocampal 
neurons compared to wild-type mice [238]. Behavioral abnormalities included disorganized 
activity, nurturing defects, anxiety-related behavior, inability to perform object recognition 
tests, and social withdrawal [238]. The wide range of effects suggested that the synaptic 
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defects were present throughout the brain, and not specific to some of its structures. However, 
STOP proteins are also present in other tissues [239]. In cycling cells, STOPs are localized 
on the mitotic spindle, whereas during interphase little localization on MTs is observed. This 
suggests that in dividing cells the role of STOP proteins is restricted to mitosis to ensure the 
fidelity of the process [239].
 Given the interest in uncovering novel MAPs, or in quickly retrieving all the related 
information for those known, a new bioinformatic tool has been developed by Zhou et al., 
which is called MAPanalyzer [240]. It consists of a manually-curated database of all known 
MAPs and of a MAP prediction tool. The prediction of new MAPs is achieved through a 
combination of two separate components. The first one is the Basic Local Alignment Search 
Tool (BLAST)(https://blast.ncbi.nlm.nih.gov/Blast.cgi) [241], which identifies regions of local 
similarity between sequences of amino acid residues. The second component consists of 
machine-learning algorithms, trained on a subset of the database. It resulted that MAPanalyzer 
performed better than BLAST and another homology-searching tool, PSI-BLAST (Position 
Specific Iterated BLAST), when they were tested separately [240]. In fact, performance 
comparisons on the curated testing datasets indicated that the sensitivity of MAPanalyzer 
was higher at the different stringency thresholds used for benchmarking. This suggested that 
MAPanalyzer is a reliable tool for predicting novel MAPs.
Molecular motors
MTs represent the railways for long range cellular trafficking, but the actual movement of 
vesicles, organelles and other cellular structures is performed by proteins that are able to bind 
and move along MTs while binding their cargo at the same time. Motor proteins of the kinesins 
family (KIF) are mostly +end directed, although some exceptions exist (see Kinesins later). The 
major -end directed motor protein in cells is not a KIF member, but is cytoplasmic dynein-1 (see 
section “Dyneins”). At present it is thought that there are at least 45 mammalian KIF genes; 
however, alternative mRNA splicing can give rise to multiple KIF isoforms, possibly leading to 
twice as many KIF proteins [242]. Kinesins and dyneins convert the energy associated to ATP 
hydrolysis into movement along MTs through complex conformational changes in their motor 
domains. 
Kinesins
Kinesins are elongated dimeric proteins with a MT-binding, globular domain with ATPase 
activity, which is mostly positioned at the N-terminus and is linked to a long intermediate 
domain (the “stalk”). Between the head and the stalk there is a linker region (“neck”), which 
has been shown to be important for the concerted, hand-over-hand movement of all kinesin 
motors; conformational changes occur in a nucleotide- and MT-dependent manner [243–247]. 
Finally, the C-terminal region is capable of binding adaptor proteins or directly their cargo. 
According to the location of the head domain, kinesins can be classified as N-terminal kinesins, 
C-terminal kinesins, or I-kinesins. In I-kinesins, such as the kinesin-13 family, constituted by 
KIF2A, KIF2B and KIF2C (MCAK) [248]), the head domain is located internally and the energy 
from ATP hydrolysis is used to depolymerize the MTs, rather than to transport cargos [249]. 
The N-terminal kinesins constitute the most abundant group of kinesins (at least 15, see [250]) 
and are mainly  +end-directed motors, in contrast with C-terminal kinesins (at least three, see 
[250] ), which are  -end-directed [251]. One head domain of the dimer binds the MT when 
bound to ATP; subsequent hydrolysis results in a decreased affinity of the domain for the MT, 
leading to its detachment from the MT, movement “over” the other head domain (now bound 
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to the MT), and translocation to a next tubulin dimer (8 nm) on the MT lattice [252–255]. At 
this point, exchange of ADP for ATP increases the affinity of this head domain for the MT, and 
the cycle starts again for the other head domain. These concerted motions allow the motor 
protein to processively “walk” with a hand-over-hand mechanism on MTs [256]. It has been 
observed that kinesins can perform hundreds of steps before dissociating from the MT, even 
in the presence of a load from an optical trap  [252,257–259].
 It should be noted that not all kinesins follow the paradigm “N-terminal head – +end 
directionality”. For instance, the kinesin-5 S. cerevisiae homolog, Cin8, despite having an 
N-terminal head domain, moves towards the -end at high ionic strengths and towards the 
+end at low ionic strengths [260,261]. Directionality and processivity seem to be dictated by 
the neck linker and its interactions with one of the ATP-bound head domains, orienting the 
other (ADP-bound) towards the +end, and so on (reviewed in [263]).  It was recently found that 
phosphorylation in the catalytic site increased velocity and promoted -end directionality, and 
decreased the binding affinity between MTs and the motor domain  [262]. 
Dyneins
Dyneins are large motor proteins: the –end-directed human cytoplasmic dynein-1 complex 
(referred to as “cytoplasmic dynein-1”), for instance, is approximately 1.4 MDa in molecular 
weight [19,264]. The first dynein was identified in Tetrahymena pyriformis in 1963: it was the 
first MT-associated ATPase capable of force generation to be described [265]. Dyneins can 
be classified in cytoplasmic and axonemal dyneins; the former is involved in cargo transport, 
including mRNA, mitochondria and vesicles [266,267], whereas the latter is responsible for 
generating the beating forces in cilia and flagella [264]. Dyneins are complexes formed by 
heavy, intermediate and light chains. Due to their large size, it has been difficult so far to 
determine their complete structure. However, it is known that the core of cytoplasmic and 
axonemal dyneins is formed by a homodimer of heavy chains (approximately 500 kDa each in 
molecular weight), whose conserved C-terminal regions contain the AAA (ATPase Associated 
with diverse cellular Activities) domains necessary for the ATPase function [268]. More 
specifically, 6 AAA domains are organized into a ring structure, stabilized by an N-terminal stalk 
structure folding on it; the stalk is also necessary for interactions with the cargo [269,270]. The 
interaction with the MT is mediated by a stem emerging from the “ATPase” ring; the propelling 
force is expressed through the movement of the stem via conformational changes in the AAA-
ring following ATP hydrolysis [271]. 
 Dynein cargo specificity is determined by the intermediate and light chains. Specifically, 
the intermediate chains contain WD repeats that are responsible for the interactions with 
p150glued [272,273], the largest of the 11 subunits of the dynactin complex [274]. This large 
complex (approximately 1 MDa in molecular weight) is one of the cofactors of cytoplasmic 
dynein, and is capable of binding different cargos, thus serving as an “adaptor” complex 
between cargo and dynein [274,275]. This function is crucial in cells, since only one dynein 
is responsible for cytoplasmic MT -end-directed transport and mitotic processes [276]. The 
affinity of dynein for p150glued is modulated by the dynein intermediate chain phosphorylation 
status [272,273]. The importance of dyneins can be exemplified in neurons. In these cells 
defects of cytoplasmic dynein motility, or disrupted interactions between cytoplasmic dynein 
and its adaptor proteins, are linked to neurodegeneration as a consequence of the impaired 
retrograde axonal transport (reviewed in [277]).
 Cytoplasmic dyneins can be further divided in two subclasses: dynein-1 and dynein-2. 
The former is involved in -end –directed cargo transport along cytoplasmic MTs and is involved 
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in a number of processes, such as karyokinesis, cytokinesis [278] and maintenance of the 
Golgi apparatus [279]. The latter, instead, takes part specifically in retrograde intraflagellar 
trafficking [280,281], with roles in the assembly and maintenance of cilia and flagella [282]. 
Cytoplasmic dyneins are characterized by a processive motion along MTs just like the 
kinesins (see section 2.2.1); however, contrary to kinesins, the precise mechanism of dynein 
processivity is yet to be elucidated. Recent studies indicated that the motions of the two heads 
are almost independent of each other [268,283], except when they are further apart, when a 
tension-driven mechanism seems to induce coordinated stepping along the MT [284].
 Axonemal dyneins, on the other hand, are responsible for the bending of cilia and 
flagella (described in section 1.4.4). Axonemal dyneins bridge adjacent MT doublets of the 
axoneme, using one of these as a track onto which their motor domains can slide, and the 
other one as a stably-bound cargo [219,264]. The sliding of MT doublets is counteracted by 
other axonemal components, resulting in bending. There are two types of axonemal dyneins 
in the axoneme, classified according to their location: inner-arm dyneins, facing the axoneme 
lumen and located every 96 nm, and outer-arm dyneins, on the opposite side and spaced by 24 
nm. The outer-arm dyneins are particularly important for generating the proper beat frequency 
[264], The processes leading to this specific arrangement of dyneins and to the coordination 
of the beating motions are still largely unknown. Given the roles presented, dyneins can be 
seen as ubiquitous proteins ensuring proper cell functionality.   
Minus-end tracking proteins (-TIPs)
-TIPs are a class of MAPs which has not been extensively studied yet. MT -  ends are often 
clustered and embedded in nucleation structures (such as the centrosome); therefore, it is 
difficult to study the properties of individual MT -ends by light microscopy. Until recently, the 
only structure known to associate to -ends was the γ-TURC [285]. Recently, it was shown that 
proteins belonging to the CAMSAP/Patronin/Nezha family also specifically bind MT -ends and 
regulate their dynamics, mainly by preventing tubulin incorporation and by protecting them 
against kinesin-13-induced depolymerization [286–288].  
 CAMSAPs (calmodulin-regulated spectrin-associated proteins), include three 
homologues, CAMSAP1, CAMSAP2 (KIAA1078/CAMSAP1L1) and CAMSAP3 (KIAA1543/
Nezha), These proteins are characterized by the presence of a common domain, called 
CKK (“C-terminal domain common to CAMSAP1, KIAA1078 and KIAA1543”, also known 
as domain of unknown function DUF1781) [287]. At their N-terminus, these proteins have a 
calponin homology domain (CHD), found also in other actin and MT-binding proteins [289]. 
However, the CHD of CAMSAPs does not interact with any cytoskeletal structure. Instead, for 
CAMPSAP1, the CKK domain interacts only weakly with the -end of MTs, and more strongly 
when together with its third coiled-coil and its preceding unstructured linker region. CAMSAP2 
and CAMSAP3 bind and stabilize the MT lattice via an additional MT binding domain located in 
the unstructured region between the second and the third coiled-coil. In particular, CAMSAP3 
is the most potent -end growth inhibitor and MT-stabilizing protein among the members of this 
family; this effect is due to an additional MT binding domain located between the third coiled 
coil and the CKK domain.
 CAMSAPs bind to dynamic or static MT -ends, and fluorescently-tagged CAMSAPs 
(especially CAMSAP2 and CAMSAP3) have been seen to accumulate stably (with a low 
turnover rate) as dots at the tip of MT -ends in vitro [290]. CAMSAP1 associates to -ends 
only transiently, in contrast to CAMSAP2 and CAMSAP3, which instead remain associated 
to the MT lattice once deposited on the newly-polymerized MT at the -end. Previous studies 
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indicated that the main function of CAMSAPs is to stabilize the -ends of free or non-centrosomal 
MTs: in fact, depletion of CAMSAP2/3 led to a decrease of non-centrosomal MTs. Moreover, 
CAMPSAPs could play a central role in the stabilization of MTs soon after the γ-TURC-initiated 
nucleation phase (reviewed by [290]). Further investigations are needed to elucidate whether 
other –TIPs exist and, if so, what roles they may play.
Plus end tracking proteins (+TIPs)
+TIPs are a subset of MAPs that are crucial for the regulation of MT dynamics. The first protein 
of this class, CLIP-170 (encoded by the CLIP1 gene), was discovered by Perez et al. in 1999 
[291]. It was proposed that this endosome-MT linker could specifically recognize the “structure 
of a segment of newly polymerized tubulin”, as GFP-CLIP-170 fluorescence was visible as 
“comet-like” dashes at the ends of growing MTs [291]. Since then, more than 20  +TIPs have 
been identified [292]. Although structurally and functionally heterogeneous, they all recognize 
and bind growing +ends. One feature that characterizes +ends is the so-called “GTP-cap” 
(see section “GTP hydrolysis and GTP cap model”); it has been suggested that +TIPs can 
recognize and bind this region with higher affinity than the rest of the MT lattice due to specific 
conformations present in the cap (see Figure 5 for a schematic and simplified representation). 
In vitro reconstitution assays revealed that the protein EB1 can recognize and bind specifically 
GTP-loaded +ends because it is able to “sense” the nucleotide state of the tubulin heterodimer 
within the MT wall [293]. In agreement with these observations, EBs show affinity for MTs 
assembled from GTP-γ-S, a nucleotide analogue with a conformation that mimics GTP in the 
transition state GDP-Pi [294,295]. 
 +TIPs can be classified in 4 groups according to structural characteristics and mode 
of binding to MT ends: EB proteins ( EB1, EB2 and EB3), CAP-Gly proteins (including CLIPs, 
p150glued, CEP350, and others), SxIP motif-containing proteins (e.g. CLASPs, APC, MCAK, 
STIM1, Navigators, KIF18B, SLAIN2, and others), and the TOG domain-containing protein 
chTOG [296,297].
End-binding (EB) proteins
Mammalian EB proteins (EBs) belong to a family comprised of three members: EB1, EB2 and 
EB3 [298]. EBs are crucial in interphase as well as mitosis [299]. Interestingly, they not only 
mediate interactions between MT ends and other structures, but can apparently also associate 
with the actin cytoskeleton [300–302]. Furthermore, overexpression of EB1 in mouse MAP-
1B-deficient hippocampal neurons was shown to compensate for the detrimental lack of MAP-
1B during axonogenesis, suggesting that EB1, when overexpressed, can stabilize MTs [303]. 
 EBs are generally homodimers of 64 kDa, but EB1 and EB3 can also heterodimerize 
[304]. While EB2 expression varies across different cell lines, EB1 is ubiquitously expressed, 
and EB3  is preferentially expressed in the central nervous system [305]. The N-terminus of 
EBs is a calponin-homology domain (CHD) which interacts directly with the surface of the MT. 
The CHD is followed by a disordered linker region, which connects the CHD to the C-terminal 
coiled coil domain; the latter mediates dimerization. At the end of the coiled-coil is the so-called 
EB-homology domain (EBH), which engages in interactions with SxIP motifs present in other 
+TIPs (such as CLASPs, described later). Following the EBH there is a flexible C-terminal tail 
of about 25 residues; the last residues (DEY in EB3 or EEY in EB1; note: the EEY sequence 
is present also at the C-termini of α-tubulin) interact with CAP-Gly domain-containing +TIPs 
(such as CLIPs, see later). EBs are capable of performing autonomous +end tracking, 
meaning that they do not require additional proteins to track +ends [195]. EBs are, together 
22
with the TOG-domain proteins (see section 2.4.3) the only proteins capable of autonomous 
+end tracking to date. Since their discovery, a growing number of proteins interacting with EBs 
has been identified; virtually all +TIPs require EBs to perform MT +end tracking [297]. This 
has obvious important consequences on the organization and regulation of the cytoskeleton, 
and disruptions of interactions between EBs and other +TIPs would therefore be detrimental 
for the cell. Therefore, given the independent +end tracking ability of EBs and the multitude of 
interacting proteins, EBs are often classified as “core +TIPs” (for review, see [297]). 
 Cryo-EM studies with the EB1 Saccharomyces pombe homolog Mal3 led to a pseudo 
atomic model for the interactions between the CHD and the MT [293]. The CHD contacts 2 
adjacent α- and 2 adjacent β- tubulin subunits in the MT lattice but not at the MT seam (where 
there are α/β lateral contacts) (Figure  3). Importantly, the CHD contacts the helix H3 of one 
β-tubulin, which is directly connected to the E-site, allowing it to “sense” the nucleotide state [293]. 
Recent very high-resolution (3.5 Å or better) cryo-EM studies of MTs together with EB3 [306], 
provided improved structural information. EB3 was found to promote inter-dimer longitudinal 
compaction; the closer distance of the residue E254 in helix H8 of α-tubulin (hypothesized to 
catalyze GTP hydrolysis, as discussed in Chapter 3) to the GTP in the E-site would promote 
GTP hydrolysis and therefore the MT maturation, as previously suggested [307]. Also, it could 
explain the catastrophe-promoting activity in vitro [191,308]. This mechanism could also be 
an explanation for the observed enhanced nucleation and sheet closure ability of EB1 [308]. 
 However, a recent study reported that EB1 inhibited nucleation [191]. This apparent 
discrepancy can be explained by considering the differences in (i) the type of assays used, and 
(ii) the different concentrations of tubulin and EB1. In fact, the former study used turbidity as a 
measure of MT nucleation, whereas the latter used a TIRF microscopy-based assay. Second, 
the EB1 concentration used by Vitre et al. was 1.5 µM, whereas it was 200 nM in the study 
by Wieczorek; similarly, Vitre and colleagues used 45 µM or 90 µM of tubulin in their study, 
whereas Wieczorek and colleagues used concentrations of tubulin ranging from 0 to 20 µM. At 
high concentrations EB1 not only binds the +end, but also the MT lattice, inducing a stabilizing 
effect. This, in turn, would promote rescues and nucleation events [308]. However, Wieczorek 
and colleagues observed that even when decreasing EB1 lattice binding by increasing the 
ionic strength of the assay buffer, the outcome remained unchanged. Nevertheless, it can be 
concluded that EBs, by virtue of their sheet closure ability (observed by electron microscopy 
by Vitre and colleagues), are able to induce faster GTP hydrolysis and thus higher catastrophe 
frequencies. In turn, this would represent an obstacle for MT nucleation, as found by Wieczorek 
and colleagues, at lower tubulin concentrations. Other experimental set-ups would perhaps 
allow a more direct comparison and an easier interpretation of the results.
 In a recent study [309], high-resolution in vitro experiments with TIRF microscopy 
showed that, upon tubulin dilution, longer EB-covered regions (“EB caps”) correlated with an 
increased MT stability. This was in line with previous observations [293], in which the size of 
the EB binding region was found to decrease before catastrophe. In particular, Duellberg et 
al. [309] provided evidence, for the first time after the original proposal in 1984 [178,310], that 
faster-growing MTs possess longer protective “caps”, which stabilize MTs and prevent them 
from undergoing catastrophe. Thus, EBs are not only indispensable “core” +TIPs ensuring 
proper localization of other +TIPs on MTs; in vitro studies show that EBs also influence 
MT dynamics per se, by increasing growth rates, and rescue and catastrophe frequencies; 
moreover, they can promote MT sheet closure and MT stability, the latter by “capping” the 
+ends. Finally, EBs alone would play an inhibitory role on MT nucleation at concentrations of 
about 200 nM with tubulin concentrations up to 20 µM (the latter presumably similar to that 
found in cells [311]). The diversity in functions and effects of EBs suggests complex regulatory 
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mechanisms.  
CLIPs
Cytoplasmic Linker Proteins (CLIPs) comprise CLIP-170 (of 170 kDa) and CLIP-115 (of 115 
kDa). CLIP-170 was first discovered in HeLa cells in 1990 [312] as a generic “170K protein”. 
The discovery was achieved using an antiserum raised against a microtubule-binding protein 
from HeLa cells. This protein (later named CLIP-170) was proposed to be involved in linking 
MTs to endocytic vesicles and was found to interact with MTs via a domain, the N-terminal 
CAP-Gly domain (cytoskeleton-associated protein glycine-rich), that was found to be present 
also in Blk1 in yeast and in the protein Glued in Drosophila [313]. Affinity-purified antibodies 
against this protein used in immunofluorescence showed a significant accumulation at the 
distal ends of MTs: it was the first +TIP to be identified, in 1999 [291]. 
 CLIP-170 is an elongated dimer; two CAP-Gly domains (per monomer) are responsible 
for the interactions with tubulin via GKNDG residues that are the hallmark of the CAP-Gly 
domains. Structural studies revealed that the shallow, positively-charged grooves in the CAP-
Gly domains harbor the GKNDG residues, which contact the EEY C-terminal residues of 
α-tubulin and EB1 [314,315]. In particular, it has been shown that the second CAP-Gly domain 
(more towards the C-terminal) has a higher affinity than the first for the EEY tail of α-tubulin 
and EB1, leaving the first CAP-Gly domain available for electrostatic interactions with the tail of 
β-tubulin. This would explain the even higher affinity for the tubulin dimer when both domains 
are in tandem [315]. The CAP-Gly domains in CLIP-170 are surrounded by three serine-rich 
regions which can modulate the binding to MTs [316]. Despite their high sequence similarity, it 
was shown that the two domains are not equivalent. The second CAP-Gly domain possesses 
a more basic groove than the first, and therefore the binding to the negatively charged terminal 
residues of EB and tubulin is enhanced [315]. This is in line with the observations by Gupta 
et al., who identified the second CAP-Gly domain, together with the third serine-rich stretch, 
as the minimal +end tracking unit in cultured cells and as nucleation/elongation factor in vitro 
[317]. Nevertheless, for optimal  +end tracking a combination of CAP-Gly domains and three 
serine-rich stretches is required [317].
 The central region of CLIP-170 is predicted to be a long coiled-coil mediating 
dimerization and causing the elongated shape of the protein; two zinc-finger domains (“zinc 
knuckles”), located at the C-terminus, can interact with other CAP-Gly-containing proteins 
(such as the dynactin p150glued subunit) or with the N-terminal CAP-Gly domains of the 
same protein. This interaction leads to a folding-back of  CLIP-170, resulting in a “closed” 
conformation [314,316] that cannot interact with MTs or other proteins. Interestingly, the binding 
determinants are the same basic grooves and the GKNDG motif involved in the interactions 
with tubulin, EB1 or p150glued [318].
 The +end-tracking ability of CLIP-170 relies on composite sites formed by the EEY 
motifs in EBs and tubulin [319]. Importantly, this implies that CLIP-170 requires tyrosinated 
tubulin in order to bind MT ends; in a model proposed by Ligon and colleagues, CLIP-170 
could interact simultaneously with one EB dimer and one tubulin dimer, thus forming a “co-
polymerization complex” directed at the tip of the polymerizing MT [320]. 
 CLIP-170 is present in many tissues, with highest mRNA expression in muscle, liver, 
testis and brain. CLIP-170 was found to be essential for spermatogenesis, as knock-out 
mice for Clip1 were viable and apparently normal, but sub-fertile [321]. CLIP-170 interacts 
at its C-terminus with different proteins, for example LIS1, which has been suggested to 
mediate the recruitment of the cytoplasmic dynein on MTs [322]. In macrophages, CLIP-170 
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is necessary for phagocytosis via its direct interaction with mDia1, a protein promoting actin 
nucleation; in this way, CLIP-170 plays an important role in actin cytoskeleton remodeling 
during phagocytosis [323]. This cross-talk with the actin cytoskeleton through mDia1 has 
been recently confirmed using in vitro reconstitution assays and TIRF microscopy [324]. 
In fact, it was observed that from CLIP-170-mDia1 complexes at the growing MT +ends, 
actin nucleation was about 18 times as fast as free barbed-end-growth of actin filaments 
[324].  In addition, knock-down experiments of Clip-170 in rat primary cortical neurons led to 
a reduction in neuronal processes. Expression of a full-length, wild-type CLIP-170 rescued 
this phenotype. Thus, CLIP-170 was found to be necessary for proper dendritic morphology 
and its association with mDia1 was suggested to be crucial. Our group has reported that 
MT dynamics is affected in CLIP-170-deficient hippocampal neurons [325], suggesting that a 
combined MT/actin defect may underlie neuronal dysfunction.
 CLIP-170 is also involved in cellular polarization. Its direct interaction with IQGAP1 
links it to Rac/Cdc42 at the cell cortex of the leading edge, driving the polarization process 
[326]. Finally, CLIP-170 also interacts with CLASPs, which will be discussed later in this 
section (Figure 3). The observation that Clip1 knock-out mice showed only spermatogenesis 
defects raises questions as to why depletion of such an important protein does not cause a 
more severe phenotype, in particular in the brain. This could be justified by the existence of a 
close homologue of CLIP-170, CLIP-115, whose functions (at least as a rescue factor in cells 
and in vitro experiments) have been suggested of being redundant with those of CLIP-170 
[327]. 
 CLIP-115 is the closest homologue of CLIP-170. It is expressed preferentially in the 
brain and is capable of performing +end tracking in the presence of EBs [328]. CLIP-115 
shares about 30% of overall identity in primary sequence with CLIP-170; however, its two 
CAP-Gly domains share a much higher degree of identity (79% for the first CAP-Gly domain, 
95% for the second). The CAP-Gly domains, surrounded by serine stretches, are followed by 
a shorter coiled-coil domain; the C-terminus lacks the Zn knuckles present in CLIP-170 [329]. 
Knock-out mice for Clip2 (i.e. the gene encoding CLIP-115) display characteristics similar to 
those of patients with Williams Syndrome (WS), which is caused by a hemizygous deletion of 
a chromosomal region of about 1.6 Mb on chromosome 7, encompassing at least 17 genes 
including CLIP2 [330,331]. WS is a developmental disease leading to a multitude of defects, 
including cardiovascular abnormalities, unusual facial features, mental and statural deficiency, 
characteristic dental malformation, and infantile hypercalcemia [330,332]. The behavioral and 
neurological characteristics include poor spatial perception, lack of fear, and coordination 
problems. In line with these features, Clip2 knock-out mice showed growth deficits and mild 
brain malformations, including a larger brain-ventricle volume and a smaller corpus callosum 
when compared to wild-type mice. Behavioral tests indicated also mild motor coordination 
defects, as well as affected hippocampal-dependent memory processes, together with a lower 
synaptic plasticity in the hippocampus [333].
 In a study by Komarova et al. [327], an engineered CLIP-170 protein was expressed 
in CHO cells. This engineered protein (“∆head-CLIP-170”) lacked the MT-binding, N-terminal 
region comprising the two CAP-Gly domains and the surrounding basic sequences. However, 
the coiled-coil region required for dimerization and the C-terminal region (involved in interactions 
with p150glued and other proteins) were still present. Overexpression of this ∆head-CLIP-170 
reduced the +end decoration of endogenous CLIP-170 and CLIP-115, while it increased their 
cytoplasmic accumulation. Ablation of CLIPs from MT +ends was accompanied by a seven-fold 
reduction in rescue frequency. Conversely, when constructs coding for the head domain only 
and for the ∆head-CLIP-170 were microinjected in cells (in a 10:1 molar ratio, respectively), 
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rescue frequencies were restored to levels comparable to control cells. It was concluded 
that CLIPs were able to promote rescues and that this property could be ascribed to their 
“head domain”, composed of the two CAP-Gly domains and surrounding basic amino acidic 
stretches [327]. However, the properties of CLIP-115 alone have never been investigated, 
mainly because of its high similarity to CLIP-170 and the supposedly redundant roles that the 
two proteins seemed to share. A thorough examination of CLIP-115 will be made in Chapter 
4 of this thesis, in which we aim at understanding whether CLIP-115 and CLIP-170 truly have 
redundant functions.
CLASPs
Cytoplasmic linker associated proteins (CLASPs) were initially identified as CLIP-interacting 
proteins using a yeast-two-hybrid assay. The most conserved region of the coiled-coils of 
CLIP-170 and CLIP-115 is the 300 residue-long, N-terminal portion, which was used as “bait” in 
the assay [334]. Two CLASP genes exist in mammals: CLASP1 (ubiquitously expressed) and 
CLASP2 (enriched in the brain). “Long” protein isoforms generated by both genes, about 170 
kDa in molecular weight, were named CLASP1α and CLASP2α. CLASP2 can be alternatively 
transcribed by using different start sites to yield shorter isoforms, of about 140 kDa, named β- 
and γ- isoforms [334]. In the fission yeast Schizosaccharomyces pombe, the CLASP ortholog 
Cls1p is a thin and elongated protein. Cls1p dimerizes via its C-terminal coiled-coil domain 
and is able to “wrap” around a tubulin dimer [335]. Conversely, human CLASP2α was found to 
be predominantly present in monomeric form [336], although size-exclusion chromatography 
experiments also revealed the existence of CLASP dimers, indicating that both forms are 
possible in solution [337].
 The N-terminus is the region that varies the most across the isoforms. The “α” isoforms 
(Figure 6) contain two TOG (tumor overexpressed gene) and one TOG-like (TOG-L) domains 
(TOG and TOG-L domains are explained below) [337] that are responsible for tubulin binding 
[335]. The β/γ isoforms, instead, lack the first TOG domain and therefore contain only two TOG 
domains [337]. Moreover, CLASP2β (which is brain specific) has an N-terminal palmitoylation 
sequence that mediates anchoring to membranes and that is not present in the other isoforms 
[334].
 TOG domains are flat, straight paddle-like domains capable of binding tubulin along 
their thin edge. They consist of approximately 220-250 residues, organized in 12 α-helices 
consecutively paired in six HEAT repeats (Huntingtin, Elongation factor-3, A subunit of PR65, 
Tor-kinase repeats) [338,339]. Intra-HEAT loops on one face of the TOG domain directly 
contact one tubulin dimer [340]. Arrays of five TOG domains are present in the MT polymerase 
XMAP215/chTOG; binding in tandem of these arrays to tubulin dimers greatly enhances the MT 
polymerization rate [335,340,341]. In their structural studies on TOG domains of the XMAP215 
family in Drosophila and yeast, Slep and colleagues noted the presence of discontinuous 
tubulin-binding determinants in two conserved central regions of the CLASP family that bore 
sequence similarity to TOG domain intra-HEAT loops. These conserved regions were termed 
“cryptic TOG-L domains” [339]. Subsequent structural studies revealed that the first TOG-L 
domain of human CLASP1α conforms to the “classical” TOG domain, whereas the second 
showed structural differences. In fact, this TOG-L (TOG-L 2) domain is curved, in contrast to 
the straight, flat surface as in the XMAP215 (chTOG) family [342]. Nevertheless, the authors 
suggested that  the TOG-L2 is a bona fide TOG domain, given its remarkable similarity in 
tertiary structure to TOG domains; therefore it will be referred to as TOG2 [342]. 
 Recently, an arched conformation was also found for the TOG domains of CLASP2α 
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[343]. It has been proposed that the different curvature of the TOG domains could serve 
as a way for CLASPs to discriminate between the tubulin states and therefore promote MT 
assembly and rescues [343]. In particular, the latter would be achieved through the association 
of the curved TOG domain to depolymerizing, curved protofilaments. Experiments with 
Xenopus laevis egg extracts showed that the TOG domains mediate MT binding, also in egg 
extracts immunodepleted of EB1, but failed to track +ends [337]. An interesting observation 
can be made at this point. The binding interface of the TOG domains with tubulin (Figure 7B 
and Figure 7C) strikingly overlaps with that of stathmin, a MT-depolymerizing and tubulin-
sequestering protein that binds two consecutive tubulin dimers (Figure 7A) [344–346]. It is 
therefore tempting to speculate about a competition between CLASPs and stathmin. Tubulin 
dimers in the soluble cytoplasmic pool could be CLASP-bound in order to be incorporated into 
polymerizing MTs (according to the model by Al-Bassam et al. [335]) or stathmin-bound to 
prevent assembly.
 C-terminal of the second TOG domain (for the α isoforms; after the first TOG domain 
for the β/γ isoforms), a serine/arginine-rich (SR-rich) region (residues 512-650 of CLASP2α) 
is subject to phosphorylation by the glycogen synthase kinase 3β (GSK3β), discussed later 
in this section. The SR-rich region is important for MT binding but especially for +end tracking 
[347], and contains two consecutive SxIP motifs for interactions with EBs at the hydrophobic 
groove in the EBH [296]. Most of the similarity between CLASP1α and CLASP2α (77% identity 
in primary structure) resides in this SR-rich region and in the C-terminal coiled-coil domain. 
This domain (residues 1171-1463 of CLASP1α)  is mainly responsible for binding proteins, 
such as  the CLIPs  and LL5β, the latter mediating interactions with the cell cortex [205,348].
 The MT binding ability of CLASPs relies mainly on electrostatic interactions involving 
the acidic C-terminal tail of tubulin. However, in vitro experiments showed that MTs subjected 
to cleavage of the tubulin tail with the protease subtilisin retained their ability to interact (to a 
lower extent than under non-treated conditions) with CLASPs. This indicated that additional 
interactions occur between CLASPs and the globular domain of tubulin subunits within the 
MTs [337]. 
 The SR-rich region of CLASP2α (residues 512-650) contains nine serine residues 
(conserved also in CLASP1α), which constitute two consensus motifs (S/T-x-x-x-S/T) [349] 
for glycogen synthase kinase 3β (GSK3β) phosphorylation [350]. It has been suggested that 
this kinase has more predicted substrates (over 500) than any other kinase [351]. Among 
the experimentally-validated substrates, there are MT-associated proteins such as APC 
[352], the von Hippel-Lindau (VHL) protein [353], Tau [354], MAP1B [355], and CLASP2 
[350,356,357]; it has been proposed that GSK3β negatively regulates MT-associated proteins 
via phosphorylation [358]. Indeed, phosphorylation of CLASP was found to disrupt its binding 
to MTs in cells [334]. In addition, when an EGFP-CLASP2 mutant construct (coding for the 
+end tracking domain (residues 512-650) and with the serines mentioned above mutated to 
alanines) was expressed in HeLa cells, the fluorescence intensity at the MT +ends was higher 
than the cells expressing the control construct. The fluorescence intensity decreased upon 
expression of a phosphomimic construct, with serines mutated to aspartate residues, similarly 
to what had been observed in cells expressing a constitutively active GSK3β (GSK3β(S9A)) 
[350]. It was found that the first SxIP motif is particularly important for the +end tracking ability, 
and phosphorylation of both motifs abolishes this, as well as MT binding. This indicated that 
CLASP2 behavior can be modulated according to the GSK3β-dependent phosphorylation 
status. It was later shown that phosphorylation of the same motif (in the context of a peptide 
including the first SxIP motif) directly controls binding to EB1, with the non-phosphorylated 
motif having an affinity 5-fold higher than the mono-phosphorylated peptide. 
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 The underlying mechanism was elucidated by molecular dynamics simulations 
together with NMR spectroscopy; it was found that phosphoserine residues in the +end 
tracking domain of CLASP2α, immediately following the fi rst SxIP motif (Ser-Lys-Ile-Pro, 
residues 728-731) could establish intra-molecular salt bridges with neighboring arginine 
residues, subtracting them from the interactions otherwise occurring with the C-terminal 
glutamates of EB1  [359]. On the other hand, phosphorylation of the second motif could 
inhibit MT binding, possibly by inducing a conformational change of CLASP. In fact, the 
second motif has a low affi nity for MTs on its own [360] and thus it would be more likely to 
promote MT binding indirectly [350]. In migrating HaCaT keratinocytes, clusters of lamella 
MTs decorated with CLASP2 were associated to focal adhesions, possibly affecting them; this 
could be dependent on CLASP2 phosphorylation status, as GSK3β inhibition disrupts focal 
adhesion dynamics [361]. GSK3β has also been shown to be involved in the regulation of 
acetylcholine receptors (AChR) delivery at the post-synaptic neuromuscular junction (NMJ) 
by acting on CLASP2γ, the only isoform expressed in muscle [356]. In fact, expression of a 
construct coding for a phosphoresistant form of CLASP2 (with the nine serines mutated to 
alanines, as described earlier) promoted MT capture at AChR clusters and increased cluster 
size. Conversely, expression of the phosphomimic construct (serines to aspartates) reduced 
MT capture and cluster size, indicating a crucial role of this kinase at the NMJ, together with 
CLASP2γ expression levels [356].
 CLASPs play a role in stabilizing MTs in proximity of the cell cortex by promoting 
rescues and inhibiting catastrophes [335,347], and at mitosis localizing at kinetochores and 
mediating their attachment to MTs [362]. A similar rescue-promoting role was found also for 
the Schizosaccharomyces pombe CLASP ortholog, Cls1p [363]. Studies in mitotic Drosophila 
cells showed that MAST/Orbit (the CLASP ortholog in this organism) is crucial for maintaining 
the length of kinetochore fi bers (K-fi bers, the MT bundles anchoring the kinetochores to the 
spindle poles) constant after their formation, contributing to proper chromosome motion. 
TOG1
TOG2
TOG-L3
S/R-rich
SxIP motif
coiled-coil
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Figure 6. Domain organization of CLASPs and their interactions. Schematic representation of the α isoforms of 
CLASPs. Arrows represent interactions between the specifi c regions of CLASPs and some of the main interaction 
partners (tubulin dimer, EBs, MTs and CLIP-170 as represented in Figure 3). Note the multiple interactions between 
the MT lattice and the TOG domains, together with the positively-charged residues C-terminal of the TOG domains 
and within the S/R-rich region (Maki et al. 2015).
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This is achieved due to the balance between the continuous addition of tubulin dimers at 
microtubule +ends (linked to the kinetochore) and their removal at the -ends within the 
pole. This phenomenon is termed “MT poleward flux” [364] and was completely lost in S2T 
Drosophila cells lacking MAST/Orbit, thus revealing a role of utmost importance for CLASPs 
[365]. Depletion of both CLASPs in HeLa cells leads to spindle defects, metaphase delay and 
abnormal exit from mitosis [362], but also to defects in interphase, such as decreased density 
of the MT network, increased MT growth rate, decreased rescue frequency, and longer (>1 
µm) depolymerization events at the cell edge [347]. During neuronal development in mouse, 
CLASP2 expression increases steadily and it localizes preferentially at the growth cones 
of neurites. Knock-down experiments for CLASP2 in primary neurons showed that axons 
and dendrites were shorter than in wild-type; overproduction of CLASP2 led to the formation 
of multiple axons, enhanced dendritic branching, and Golgi condensation, highlighting its 
importance in neuron morphogenesis and polarization [366]. However, in another study 
CLASP2-depleted neurons displayed enhanced axon growth and reduced dendrite branching, 
whereas CLASP1 depletion had little effect [367]. Additionally, knockdown of all isoforms of 
GSK3 impaired axon growth. This effect was reversed by knocking down CLASP2, indicating 
that CLASP2 is the major GSK3 target for axon growth inhibition. On the other hand, depletion 
of GSK3 increased branching in a CLASP2-independent fashion, thus suggesting that 
CLASP2 plays a major role in axon growth rather than branching, for which other proteins are 
A B C
Figure 7. Comparison of TOGs-tubulin and stathmin-tubulin binding interfaces. (A) Structures of two tubulin dimers 
(cartoon representations) in complex with a stathmin-like domain (orange) (PDB: 1SA0 (Ravelli et al. 2004)). α- and 
β-tubulin are colored in blue and red, respectively. (B) Structure of the “classical” straight TOG2 domain (magenta) of 
the Saccharomyces cerevisiae Stu2p protein, ortholog of the XMAP215/chTOG MT polymerases, bound to a tubulin 
dimer (PDB: 4U3J (Ayaz et al. 2014)). The α-subunit (light blue cartoon) of this complex was aligned to the α-tubulin 
of the structure 1SA0 (dark blue cartoon) across their α-carbon traces to compare the overlapping binding interface. 
(C) Similarly, the α-carbon trace of the TOG2 domain (green) of human CLASP2 (PDB: 3WOY (Maki et al. 2015)) 
was aligned with the TOG2 domain of Stu2p, in magenta in Figure 5B. Note the arched conformation compared to the 
TOG2 domain of Stu2p, as well as its overlap at the tubulin-binding interface with the stathmin-like domain (orange). 
Figures generated with Chimera (Pettersen et al. 2004).
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important [367]. The contrasting results between these two studies could be thus depending 
on the prevalent GSK3-induced phosphorylation status of CLASP2 at a given time.
 The association of CLASPs to CLIP-170 was first shown in COS-1 (T-antigen of SV40 
expressing AGMK cells, African Green Monkey Kidney cells) and NIH-3T3 fibroblasts and 
through yeast two-hybrid assays; this was corroborated by immunofluorescence experiments 
which revealed an overlapping distribution of CLASP2 and CLIP-170 at MT +ends. The direct 
interaction was confirmed with in vitro experiments, which indicated that the C-terminus of 
CLASPs is involved in such interaction with the region of the CLIP proteins located after 
the second CAP-Gly domain (Figure 4). CLASPs were found to accumulate at the Golgi 
apparatus and, in motile NIH-3T3 fibroblasts, CLASP2 accumulated at the leading edge. 
This localization pattern was in contrast to that of CLIPs or EB1, which localized at +ends of 
MTs in the cell interior, and not at the Golgi [334]. It was proposed that interactions between 
CLIPs and CLASPs play a fundamental role in MT dynamics in polarized cells. In particular, 
CLASPs could attract CLIPs to MT ends, even in conditions that would otherwise lead to CLIP 
dissociation (i.e., shrinking or pausing events), to promote MT rescues. These aspects are 
discussed in greater detail in Chapter 4 of this thesis.
 In conclusion, the +TIP networks that are established on MTs can be extremely 
complex and diverse. Among the roles of +TIPs we have encountered effects on MT dynamics, 
interactions with organelles, chromosomes and the cell cortex. We have discussed how a 
family of these +TIPs, CLASPs, can be regulated at a post-translational level. One of the 
most striking features of +TIPs, perhaps, is that a common player is usually required for 
proper +end binding of virtually all +TIPs: the EB proteins. Also, the observations presented 
in this section highlight the uniqueness of +ends themselves, which could be considered as 
“regulatory hubs” for MT behavior, driven by specific combinations of +TIPs. 
Molecular dynamics simulations
In this section, a brief and general overview of a method used in theoretical biophysics (i.e., 
molecular dynamics) is provided, since the study described in Chapter 3 has been performed 
using such method.
Background
Molecular dynamics (MD) simulations are a computational method to investigate the behavior 
of an atomic system over time; in the biological context, this system is usually represented 
by high-resolution atomic structures of proteins, solved by X-ray crystallography or nuclear 
magnetic resonance (NMR). The fields to which MD simulations can be applied are very 
diverse, ranging from chemistry to biology, engineering and physics. In MD simulations, atoms 
are treated as inelastic hard spheres - obeying the second principle of motion- and covalent 
bonds as springs - usually described by Hooke’s law-. Empirically-derived parameters from 
chemistry and physics experiments are specified by a force field (such as CHARMM [368]), 
which is an additive function describing the potential energy as the sum of different energy 
contributions in the system under study. These energy contributions are represented by 
“bonded” and “non-bonded” energies. The former includes the energies associated to the 
covalent bond interaction, the angle of the bond, and the dihedral (the angle between two 
intersecting planes defined by three atoms each, two of which are in common). Non-bonded 
energies include electrostatic and van der Waals interactions. In all-atom simulations, all 
atoms (therefore, including hydrogen) and bonds are subjected to classical mechanics’ laws 
to infer their behavior in space and time.
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 An essential step in performing MD simulations is represented by structure 
preparation and minimization. Structures determined experimentally may be incomplete or 
could be unrefined, displaying distorted bond lengths and angles, or may have steric clashes. 
Therefore, energy minimization is required before running an MD simulation, apart from 
refinement purposes. Energy minimization aims at finding the energy minima for each atom in 
the structure, to achieve a relaxed state of the system.
 The first MD simulation applied to a biological macromolecule, the bovine pancreatic 
trypsin inhibitor (BPTI), was published in 1977 [369]. This simulation was carried out in 
vacuum (therefore, not in physiological conditions) and for only 9.2 ps; it corroborated the 
hydrogen-exchange experiments between peptides and water of Lindestrom-Lang et al. in 
1955. It became clear that proteins were not fixed arrangements of atoms, but rather dynamic 
entities. In 1979, Frauenfelder et al. [370] proposed that thermal factors (B factors) determined 
from X-ray crystallography experiments could offer an estimate of such mobility and since 
then much effort has been invested in gaining more insight into protein dynamics, an essential 
prerequisite for protein function. Since the first MD simulation, the computational speed and 
the development of force-fields and of the simulation software increased steeply. To date, MD 
simulations can be performed on larger systems (hundreds of thousands of atoms), in explicit 
solvent (meaning that water molecules are present in the system and participating in the 
simulation), and for much longer times. As an example, in 2009 the supercomputer Anton, with 
its 512 nodes, performed MD simulations for more than one ms of biological time on the BPTI 
mentioned earlier, a time span 100 million times longer than the first MD simulation [371]. A 
general, simplified workflow for the set-up of an MD simulation is depicted in Figure 8.
Applications
MD simulations have been increasingly used in biology to understand elusive molecular 
mechanisms at the atomic level or to make predictions that can be cross-validated 
experimentally; however, estimates of systematic errors of computations have not been 
possible so far. Some applications consist in sampling the conformational space of an 
experimental structure (for example, during structure refinement): MD simulations are very 
often used in conjunction with NMR experiments [372]. Also, MD simulations allow analyzing 
the actual protein motions in time, such as for the bacterial chaperonin GroEL [373]. In this 
study, the structural transitions that take place between the closed and open conformations of 
GroEL were identified.       
 Another example is given by the dynamic gating of acetylcholinesterase, where a 
10-ns simulation revealed details that were not deducible from experiments. In this study, MD 
simulations allowed the determination of conformations that govern substrate specificity of 
the enzyme. An “aromatic gate” represented by fluctuating side chains of aromatic residues 
allowed, within a short timeframe, the quick access of acetylcholine but this timeframe was 
insufficient for entry of bulkier substrates [374].
 One of the most common fields of application of MD is drug design [375]. Design of 
pharmacophores and optimization of existing drugs (to enhance their selectivity, for example) 
rely extensively on molecular modelling and on MD simulations. They allow insight into the 
mode of binding of the candidate drug onto the target structure, but also about the structural 
consequences upon binding. Other applications of MD simulations include in silico protein 
folding studies [376], investigation of conformational and allosteric properties [377], studies on 
enzyme dynamics required for catalysis [378]. In conclusion, MD simulations are a powerful 
tool to discover or validate atomic mechanisms of dynamic processes; however, they should 
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always be accompanied by experimental evidence, to confirm the predictions or to improve 
the methodology. 
experimental structure
available? (homology) 
modelling
N
Y
missing 
elements?
Y
structure check
(chirality, bonds, 
clashes)
N
solvation
neutralization
His protonation state
minimization (0 K)
heating
equilibration (310 K)
production run
Are RMSDs 
stable?
 
ANALYSIS
Y
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Figure 8. Simple general workflow for the preparation of a molecular 
dynamics simulation. The quality of the starting structure is crucial 
for a reliable output of an MD simulation. Structure modelling may be 
necessary, followed by a check of proper chirality of residues, lengths 
and angles of bonds and possible steric clashes between side chains; 
the protonation state of histidine residues must be set in function of 
the desired pH of the environment. The structure is solvated by add-
ing water molecules to embed completely the protein of interest (con-
sidering also possible large structural rearrangements); the system is 
then made electrically neutral by adding ions accordingly. Relaxation 
of the protein is achieved through minimization, carried out at 0 K and 
followed by gradual heating up to the target temperature, usually 310 
K (37°C) for biological systems.  The system is considered equilibrat-
ed when RMSDs (root-mean square deviations from initial structure) 
do not vary steeply anymore. Once the system is equilibrated, the 
production run phase starts and can be carried out for the desired 
amount of time. At the end of the simulation, the trajectory of the mol-
ecule is analyzed with dedicated tools.
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SUMMARY
The microtubule (MT) cytoskeleton forms a dynamic
filamentous network that is essential for many pro-
cesses, including mitosis, cell polarity and shape,
neurite outgrowth and migration, and ciliogenesis
[1, 2]. MTs are built up of a/b-tubulin heterodimers,
and their dynamic behavior is in part regulated
by tubulin-associated proteins (TAPs). Here we
describe a novel system to study mammalian tubu-
lins and TAPs. We co-expressed equimolar amounts
of triple-tagged a-tubulin and b-tubulin using a 2A
‘‘self-cleaving’’ peptide and isolated functional fluo-
rescent tubulin dimers from transfected HEK293T
cells with a rapid two-step approach. We also pro-
duced two mutant tubulins that cause brain malfor-
mations in tubulinopathy patients [3]. We then
applied a paired mass-spectrometry-based method
to identify tubulin-binding proteins in HEK293T
cells and describe both novel and known TAPs.
We find that CKAP5 and the CLASPs, which are
MT plus-end-tracking proteins with TOG(L)-do-
mains [4], bind tubulin efficiently, as does the
Golgi-associated protein GCC185, which interacts
with the CLASPs [5]. The N-terminal TOGL domain
of CLASP1 contributes to tubulin binding and allows
CLASP1 to function as an autonomous MT-growth-
promoting factor. Interestingly, mutant tubulins bind
less well to a number of TAPs, including CLASPs
and GCC185, and incorporate less efficiently into
cellular MTs. Moreover, expression of these mu-
tants in cells impairs several MT-growth-related
processes involving TAPs. Thus, stable tubulin-
TAP interactions regulate MT nucleation and growth
in cells. Combined, our results provide a resource
for investigating tubulin interactions and functions
and widen the spectrum of tubulin-related disease
mechanisms.
RESULTS AND DISCUSSION
Production of Functional Tubulin in Mammalian Cells
Microtubules (MTs) are filaments composed a/b-tubulin hetero-
dimers that interact in a head-to-tail manner to form protofila-
ments, 13 of which fold up through lateral interactions to make
a hollow MT tube. Assembly, or disassembly, of a MT occurs
by the addition, or removal, of tubulin dimers at the ends. One
end of a MT, called the minus end, is often embedded in a pro-
tective structure such as the centrosome, whereas the plus
end undergoes cycles of polymerization, pausing, and depoly-
merization, a behavior termed dynamic instability [6].
Functional (i.e., assembly-competent) tubulin can be purified
from pig or cow brain tissue through repeated cycles of polymer-
ization, high-speed sedimentation of MTs, and depolymerization
[7]. Brain tubulin is widely used in in vitro studies, but since mul-
tiple a- and b-tubulin isotypes exist that are encoded by different
genes [8], brain-derivedMTs are of amixed isotype composition.
Efforts toward isolating recombinant tubulin isotypes are
hampered by the fact that tubulin biosynthesis is quite complex,
involving chaperones that bind to nascent tubulin polypeptides,
cytosolic chaperonins (CCTs) that facilitate folding of intermedi-
ate tubulinmonomers, and tubulin-specific folding cofactors that
allow formation of native heterodimers [9]. Nevertheless, purified
assembly-competent recombinant human tubulin was recently
obtained from baculovirus-infected insect cells, allowing studies
of isotype function [10]. However, non-cleavable affinity tags
were placed at the C terminus of both the a- and b-tubulin sub-
units, and these may influence MT behavior. Furthermore,
expression in insect cells precludes analysis of mammalian-spe-
cific tubulin-associated proteins (TAPs).
We designed a so-called ‘‘dual’’ tubulin expression construct
(Figure 1A) for the production and isolation of recombinant tubu-
lins in mammalian cells. This construct consists of a fusion cDNA
encoding b-tubulin (TUBB3) followed by a short sequence en-
coding a P2A ‘‘self-cleaving’’ peptide [11] and triple-tagged
a-tubulin (TUBA1A). The triple tag, whichwas placed at the N ter-
minus, contains a biotin-recognition sequence (biotinylated by
the bacterial BirA enzyme), a Sumo* substrate peptide (recog-
nized by Sumo* protease), and GFP (Figure 1A, top). Upon trans-
lation of the ‘‘dual’’ construct mRNA, the short P2A peptide
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cleaves in an autocatalytic fashion, resulting in the production of
equimolar amounts of TUBB3 with part of the P2A peptide at its
C terminus (TUBB3-P2A) and tagged TUBA1A. Analysis of the
modeled structure of the tagged a/b-tubulin dimer indicated
that bio-Sumo*-GFP at the N terminus of a-tubulin is not in the
vicinity of the a/b-tubulin dimer interface (Figure 1A, bottom).
As controls for the ‘‘dual’’ construct, we made ‘‘single’’ bio-
Sumo*-GFP-TUBA1A constructs, as well as another ‘‘dual’’
version in which we placed a bio-Sumo*-tag at the N terminus
of b-tubulin instead of a-tubulin (Figure S1A).
We expressed ‘‘single’’ or ‘‘dual’’ constructs in HEK293T cells
together with a plasmid encoding the BirA biotin ligase. Trans-
fected cells were lysed, and biotinylated tubulin was purified us-
ing streptavidin-coated magnetic beads. After washing, proteins
were cleaved off of the beads with Sumo* protease. SDS-PAGE
followed by Coomassie staining (Figures 1B and S1B) or western
blotting (Figures S1C and S1D) was used to examine protein
expression, purification, and cleavage. We detected biotinylated
and Sumo*-GFP-tagged a-tubulin (110 kDa) on beads after
purification. Cleavagewith Sumo* protease resulted in the disap-
pearance of the 110 kDa protein and the appearance of GFP-
a-tubulin (85 kDa). In addition, we co-purified proteins of
55kDa (Figures 1B and S1B), which were identified as tubulins
by western blot (Figures S1C and S1D), and proteins of70 kDa
(asterisks in Figures 1B and S1B), which are discussed below.
When wild-type GFP-TUBA1A was expressed using the ‘‘dual’’
construct, the amount of b-tubulin that co-purified with GFP-TU-
BA1A was higher compared to the ‘‘single’’ construct due to
increased TUBB3-P2A (compare Figure 1B with Figure S1B).
This indicates that simultaneous synthesis of a- and b-tubulin
polypeptides promotes dimer formation. Furthermore, tubulin
dimer pull-down was less efficient when the biotin tag was
placed at the N terminus of b-tubulin (data not shown). Taken
together, these data suggest that our production and isolation
method yields soluble recombinant tubulin and that dimer pull-
down is most effective when a-tubulin is tagged.
The conformation of HEK293T-purified wild-type tubulin was
examined by gel filtration. Compared to brain tubulin, which
A B
E
C
F
D
G
Figure 1. Isolation of Functional Tubulin
(A) Schematic representation of the ‘‘dual’’ tubulin
expression construct (top) and ribbon visualization
of triple-tagged a/b-tubulin (bottom). The position
of the single point mutations is indicated. In the
model, a-tubulin is in blue, b-tubulin is in red, GFP
is in green, Sumo* is in pink, and the bio tag is in
orange. Amino acids P263 (cyan) and R402
(magenta) are indicated.
(B) Coomassie-stained gel showing purification
and cleavage of tubulins, derived from ‘‘dual’’
tubulin expression in HEK293T cells. B, beads;
B+Pr, Sumo* protease-treated beads; S, soluble
proteins released from beads after Sumo* prote-
ase treatment; M, marker lane (molecular weights
are indicated to the right). The asterisk indicates
proteins of 70 kDa co-purifying with GFP-tubulin.
(C) Size-exclusion chromatography of GFP-tag-
ged tubulin purified from HEK293T cells (HEK
tubulin) and brain tubulin. Proteins were run
separately on a Superdex 200 column, and elution
profiles were monitored using absorbance at
280 nm. Size markers (Mr, indicated in kDa above
the graph) were independently applied to the
same column.
(D) Coomassie-stained gel of column fractions a–h
from size-exclusion chromatography in (C).
Dimeric GFP-tubulin peaks in fractions c and d,
whereas complexes of GFP-tubulin with 70 kDa
HSPA proteins (*) peak in fractions e and f. M,
marker lane (molecular weights are indicated to
the left).
(E) Coomassie-stained gel showing result of MT
sedimentation assay. After sedimentation, the
supernatant (S) and pellet (P) fraction of each
experiment was loaded on gel. M, marker lane
(molecular weights are indicated to the left).
(F) In vitro MT polymerization assay showing that
purified GFP-tubulin incorporates into MTs. The
left panels show still images (see Movie S1 for the
corresponding time-lapse experiment). Arrows indicate theMT ends of the GFP-TUBA1A-reconstituted fluorescent MT. The right panel is a kymograph (distance
versus time plot) showing the dynamic behavior of a single MT.
(G) Parameters of dynamic MTs incubated with the indicated proteins. Data are shown ±SD. The average growth speed of MTs incubated with fluorescent
a-tubulin is higher than that of MTs with EB3 only, whereas shrinkage speeds are similar. For comparison, see Figure 2E.
See also Figure S1 and Movie S1.
Current Biology 26, 1728–1736, July 11, 2016 1729
53
Chapter 2
eluted as a single dimeric species, HEK-purified GFP-tagged
tubulin eluted slightly earlier (Figure 1C), consistent with the
presence of a GFP moiety on tubulin. SDS-PAGE and Coomas-
sie staining of eluted fractions suggested that this peak con-
sisted of GFP-a-tubulin/b-tubulin heterodimers and complexes
of GFP-tubulin with 70 kDa proteins. A mass-spectrometry-
based analysis of purified fractions revealed that the latter are
HSPA heat shock proteins (data not shown). We next mixed
HEK-purified tubulin with brain tubulin and GMPCPP (a slowly
hydrolyzable GTP analog), allowed MTs to form, and performed
aMT sedimentation assay. Approximately 70% of the total HEK-
purified GFP-a-tubulin incorporated into MTs (Figure 1E).
Furthermore, an in vitro total internal reflection fluorescence
(TIRF)-microscopy-based assay [12], in which a mixture of puri-
fied GFP-TUBA1A, brain tubulin, and other components was
added to a functionalized chamber with GMPCPP-stabilized
MT seeds, revealed incorporation of fluorescent tubulin into
dynamic MTs (Figure 1F; Movie S1). Thus, GFP-tagged tubulin
produced using the ‘‘dual’’ strategy is assembly competent.
The importance of the different tubulin isotypes for neuronal
function is underscored by the finding of mutations in the tubulin
genes that give rise to a spectrum of human neuro-develop-
mental disorders. These are collectively called tubulinopathies,
and they arise because of problems in neuronal migration or dif-
ferentiation [3]. To study mutant tubulins, we introduced twomu-
tations (P263T and R402H) into TUBA1A (Figure 1A) that lead to
problems in vivo [13] but that do not impair the capacity of
mutant tubulins to form heterodimers in vitro [14]. Expression
of the P263T and R402H mutants in differentiating N1E-115
cells indeed affected neurite outgrowth (Figures S1E and S1F).
The tagged mutant tubulins were purified in soluble form from
HEK293T cells and were cleaved with Sumo* protease, like
wild-type tubulin (Figure S1D).
Collectively, our data demonstrate that the isolation of recom-
binant tubulin from transiently transfected HEK293T cells using a
‘‘dual’’ expression method followed by biotin-streptavidin pull-
down andSumo* protease cleavage yields assembly-competent
fluorescent a/b-tubulin dimers. This approach can be further
developed to study tubulin isotypes, also from different species,
and the effect of tubulin mutations on MT behavior in vitro. It
should be noted that tubulins undergo a number of posttransla-
tional modifications (PTMs), some of which occur on the C-termi-
nal residues of a- and b-tubulin [15]. In our ‘‘dual’’ expression
approach, the C terminus of b-tubulin contains part of the P2A
‘‘self-cleaving’’ peptide; this is highly likely to impair C-terminal
PTMs on this subunit.
Identification of Tubulin Associated Proteins
The dynamic behavior of MTs is regulated both by TAPs andMT-
associated proteins (MAPs). The latter are often divided into sub-
groups according to their mode of association with MTs. For
example, ‘‘classic’’ MAPs, like MAP2, MAP1B, and MAP4, bind
along the MT lattice, motor proteins move along MTs, and MT
plus-end-tracking proteins (+TIPs) associate specifically with
the ends of growing MTs. Although many MAPs and +TIPs
have been identified over the years, we are aware of only two un-
biased approaches to detect TAPs. In the first, a tubulin affinity
matrix was used; this strategy yielded 122 potential plant
TAPs, of which one was a tubulin chaperone and six others,
including plant CLASP, were similar to known MAPs [16]. In the
second approach, a tubulin-antibody matrix was used to isolate
TAPs from extracts of HeLa cells [17]; however, this indirect
approach did not yield a high number of proteins.
To identify mammalian TAPs, we expressed tagged tubulins in
HEK293T cells, purified them on streptavidin beads, and used a
paired mass-spectrometry-based approach to screen for inter-
action partners. In this strategy, one sample contained proteins
that were boiled off streptavidin beads and identified by mass
spectrometry, whereas in a second sample the streptavidin-
linked material was treated with Sumo* protease and the
released proteins were analyzed by mass spectrometry. The
rationale behind this approach is that proteins that show a strong
preference for tubulin-bound streptavidin beads and that are
efficiently released by Sumo* protease are likely to be TAPs.
By contrast, contaminants such as endogenously biotinylated
mitochondrial proteins should be present in the bead fractions
of the different samples, including the negative control (Bio-
Sumo*-GFP), but not in Sumo*-protease-released fractions.
We obtained 3,091 entries for proteins co-purifying with
‘‘dual’’ tubulin (Table S1). Although most TAPs were novel,
some were previously shown to bind tubulin, validating our
approach. In addition, we did not detect MAP1B, MAP2, or
MAP4, the +TIPs EB1 or EB3, or conventional kinesin, indicating
that the pull-downs were specific for TAPs. We verified mass
spectrometry results using western blot analysis and showed
that four prominent TAPs (i.e., CKAP5, CLASP1, CLASP2,
and GCC185 [or GCC2]) did bind tubulin, whereas EB1, the
‘‘core’’ +TIP that recruits many other +TIPs to MT ends [18],
did not (Figure S2A). We also showed that the ‘‘dual’’ construct
depicted in Figure 1A brings down TAPs more efficiently than
other constructs (Figures S1A and S2B). Together, these results
indicate that the proteins listed in Table S1 represent a consider-
able fraction of the HEK293T cell ‘‘tubulome.’’
By applying stringent criteria (see the Supplemental Experi-
mental Procedures for explanation) we selected the 45 most
prominent TAPs and classified these according to known func-
tion or localization (Table 1). Of these TAPs, the majority (80%)
are novel. To estimate their abundance, we examined the
HEK293T transcriptome using next-generation sequencing.
This revealed that most TAPs are expressed at considerably
lower levels than the chaperonins, which have FPKM (fragments
per kilobase of transcript per million mapped reads) values of
well over a 100 (data not shown). Thus, the presence of the
TAPs in Table 1 appears to reflect an affinity for a-tubulin, rather
than cellular abundance.
We observed several general features in Table 1. First, many of
the TAPs interact with other TAPs, often of the same category.
For example, CEP97 and CCP110 are interacting centrosomal
proteins with a role in preventing excessive centriole growth
[19]. Also, CLIP-115 binds the CLASPs [20], and SLAINs have
been shown to interact with CLASPs, CKAP5, and CLIP-115
[21]. These results suggest the existence of higher-order
tubulin-TAP complexes with important functions in MT and/or
centrosome and/or cilia behavior. For example, the tubulin-
binding +TIPs might form a core network that promotes MT
growth at plus ends and other intracellular sites. A second obser-
vation, which was verified by western blot (Figure S2C), was that
for a number of TAPs, including the CLASPs, GCC185, and
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Table 1. Characterization of Mammalian Tubulin-Associated Proteins
Descriptiona Symbol RNAb
WT-ac P263T R402H WT-b
Td Interactionseb a b a b a b a
+TIPs
Cytoskeleton-associated protein 5 CKAP5 53 98 102 96 94 100 99 42 3 Y TACCs, SLAINs
CLIP-associating protein 1 CLASP1 4.9 49 41 31 27 46 26 I CLIP2, GCC2, SLAINs
CLIP-associating protein 2 CLASP2 6.1 30 25 10 7 18 7 I CLIP2, GCC2, SLAINs
Transforming acidic coiled-coil-containing
protein 1
TACC1 4.7 15 20 16 25 15 19 N CKAP5
SLAIN-motif-containing protein 1 SLAIN1 9.4 12 9 12 8 14 8 N CLASPs, CLIPs, CKAP5,
TACC2, KIF2A
SLAIN-motif-containing protein 2 SLAIN2 2.9 11 8 10 7 11 7 N CLASPs, CLIPs, CKAP5,
TACC2, KIF2A
CAP-Gly domain-containing linker protein 2 CLIP2 2.4 6 8 2 I CLASPs, CKAP5, SLAINs
Adenomatous polyposis coli protein APC 2.1 6 5 5 N
Centrosomal
Centrosomal protein of 290 kDa CEP290 9.8 67 12 64 10 45 4 N CCP110, CEP97, IQCB1
Transforming acidic coiled-coil-containing
protein 2
TACC2 2.1 35 41 41 44 41 42 N CKAP5, SLAINs
Centrosomal protein of 170 kDa protein B CEP170B
(KIAA0284)
7.8 29 16 10 5 N KIF2b, but not KIF2a
or KIF2c
Centromere protein J CENPJ 4.8 29 4 24 5 26 4 Y
Centriolar coiled-coil protein of 110 kDa CCP110
(CEP110)
3.7 27 18 21 20 20 16 N CEP97, Neurl4, CEP290
Centrosomal protein of 97 kDa CEP97 4.5 16 14 13 17 10 9 N CCP110, Neurl4 (indirectly),
CEP290, CEP97
Abnormal spindle-like microcephaly-
associated protein
ASPM 1.6 20 2 9 28 N
WD-repeat-containing protein 62 WDR62 11 18 13 2 1 N CEP170
Ninein NIN 14 9 13 12 N CEP170
Pericentriolar material 1 protein PCM1 7.4 9 7 3 N
Centrosomal protein of 85 kDa like CEP85L
(C6orf204)
4.2 5 4 11 6 15 5 N
Motor
Kinesin-like protein KIF14 KIF14 6.8 32 9 29 4 22 5 2 Y KIF4A(*)
Chromosome-associated kinesin KIF4A KIF4A 17 27 27 9 7 10 N KIF14
Kinesin-like protein KIF2A KIF2A 17 26 30 25 27 17 18 1 2 N
MT Associated
MAP7 domain-containing protein 1 MAP7D1 25 26 26 13 11 27 23 9 6 N NEURL4
Janus kinase and microtubule-interacting
protein 1
JAKMIP1 3.2 16 2 4 5 N
Ensconsin MAP7 7.4 10 9 3 3 5 7 4 3 N
Not Categorized
GRIP and coiled-coil-domain-containing
protein 2
GCC2 5.2 26 38 2 9 6 11 N CLASPs
Lamin-B1 LMNB1 89 15 21 1 22 6 N LMNA
Alpha-internexin INA 1.4 13 9 9 5 N PP1CA
Lamin-B2 LMNB2 61 13 11 12 2 N LMNA
Prelamin-A/C LMNA 31 10 13 6 N LMNB1/2
Serine/arginine-rich splicing factor 1 SRSF1 96 9 10 5 8 2 5 N
KIAA1671 [hgnc:29345] KIAA1671 3.2 9 4 5 4 N
HCLS1-associated protein X-1 HAX1 150 8 6 9 8 9 9 1 3 Y HSPs
rRNA 20-O-methyltransferase fibrillarin FBL 591 8 9 7 3 Y
(Continued on next page)
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various centrosomal components, fewer unique peptides were
found in themass-spectrometry-based pull-downs of themutant
tubulins (Tables 1 and S1). Finally, several TAPs (underlined in
Table 1) have been found mutated in patients with brain malfor-
mations or ciliopathies. This underscores the importance of
TAPs for brain development and ciliogenesis. It would be inter-
esting to investigate whether other TAPs in Table 1 are mutated
in patients with neurological symptoms.
Tubulin Binding Stimulates the MT-Growth-Promoting
Capacity of CLASP1
Among the highest-ranking TAPs in the ‘‘tubulome’’ of HEK cells
are CKAP5 (also called XMAP215 or Ch-TOG) and the CLASPs,
which are +TIPs with similar domains, termed TOG in the case of
CKAP5 and TOGL in the case of CLASPs [4]. CKAP5 acts as a
MT polymerase by binding tubulin subunits with its TOG do-
mains and mediating the incorporation of tubulin at MT ends
[22]. Tubulin binding has also been described for yeast CLASP,
which was suggested to promoteMT rescue by recruiting tubulin
dimers to the MT [23], but not for mammalian CLASP1 and
CLASP2. These proteins are encoded by different genes and
exist as multiple isoforms [20], the longest of which (a) contains
three TOGL domains, whereas shorter isoforms (b, g) only have
two (Figure 2A). Recent studies suggest that the TOGL domains
in CLASP2g do not have an optimal tubulin-binding interface as
they assume a curved conformation; these domains were
instead proposed to have a preference for MTs [27]. To examine
tubulin binding by CLASP isoforms, we co-expressed bio-
tinylated and GFP-tagged ‘‘dual’’ tubulin together with YFP,
YFP-CLASP1a, or YFP-CLASP2g, pulled down biotinylated
tubulin, and found that YFP-CLASP1a co-precipitated much
more efficiently than YFP-CLASP2g (Figure 2A, bottom). These
results suggest that the TOGL1 domain contributes significantly
to tubulin binding of CLASP1a.
The majority of +TIPs, including the CLASPs, have been
shown to harbor a small domain (called the SxIP motif) with
which they interact with EB proteins and that allows them
to accumulate at growing MT ends [18]. In fact, the EB
proteins are seen as the ‘‘core’’ +TIPs because they attract
most other +TIPs yet bind MT ends in an autonomous fashion
[12]. We purified GFP-tagged CLASP1a and CLASP2g from
HEK293T cells (Figures 2B, S3A, and S3B), as well as GFP-
tagged and non-tagged (‘‘dark’’) EB3 (Figures S3C and S3D
and data not shown), and examined binding of CLASP isoforms
to in vitro-grown MTs, as well as their effect on MT dynamics,
using the aforementioned TIRF-microscopy-based assay.
CLASP2g displayed typical +TIP behavior as it accumulated
on MT ends in the presence of EB3 (Figures 2C and 2D) and
did not bind MTs in the absence of EB3 (data not shown). Strik-
ingly, CLASP1a bound to MT ends and the MT lattice in the
absence of EB3; addition of the ‘‘core’’ +TIP shifted CLASP1a
binding toward the MT end (Figures 2C and 2D). Thus, the pres-
ence of the tubulin-binding TOGL1 domain allows CLASP1a to
bind MTs and MT ends autonomously.
We then measured dynamic parameters of in vitro-polymer-
izing MTs grown in the presence or absence of EB3 and the
Table 1. Continued
Descriptiona Symbol RNAb
WT-ac P263T R402H WT-b
Td Interactionseb a b a b a b a
Casein kinase I isoform alpha CSNK1A1 40 8 6 1 N HMMR1, FAM83D, APC
Zinc-finger C2HC domain-containing
protein 1A
ZC2HC1A 2.6 7 8 5 8 11 5 N
Tubulin-folding cofactor B TBCB 55 7 6 8 7 3 2 Y tubulins
Hyaluronan-mediated motility receptor HMMR 21 7 15 N CSNK1A1
IQ calmodulin-binding motif-containing
protein 1
IQCB1 35 6 7 N CEP290
Zinc-finger and BTB domain-containing
protein 21
ZBTB21
(ZNF295)
4.6 6 3 3 N
Protein FAM83D FAM83D 12 6 7 2 N CSNK1A1
Mitochondrial inner membrane protein IMMT 63 5 10 3 N HSPs
Protein phosphatase 1 regulatory
subunit 12A
PPP1R12A 10.8 5 4 4 2 N
T-complex protein 11-like protein 2 TCP11L2 1.7 5 5 8 6 18 16 2 N
Catenin beta-1 CTNNB1 71.9 5 2 2 6 4 2 N
See also Figure S2 and Table S1.
aTAPswere categorized into groups based on localization or function. In each group, proteinswere sorted in descending preference for the ‘‘b’’ fraction
of tagged wild-type a-tubulin. For the underlined TAPs, the corresponding gene was found mutated in a brain malformation and/or ciliopathy patient.
bmRNA levels in HEK293T cells as determined by RNA sequencing (FPKM values).
cUnique peptides from the paired mass spectrometry analysis. WT-a, pull-down with tagged wild-type a-tubulin; P263T and R402H: pull-down with
the respective tagged mutant a-tubulins; WT-b, pull-down with tagged wild-type b-tubulin. b, proteins boiled off the streptavidin beads (i.e., before
cleavage); a, proteins released by Sumo* protease (i.e., after cleavage).
dColumn lists whether a TAP is known (Y) or novel (N) or whether tubulin binding can be inferred (I) based on data with similar proteins from lower
eukaryotes.
eInteractions with other TAPs in the table, based on Uniprot database and literature searches.
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CLASPs. The addition of EB3 and GFP-CLASP1a or of EB3 and
GFP-CLASP2g caused a general dampening of MT dynamic
behavior compared to MTs grown in the presence of EB3 only
(Figure 2E). Interestingly, when added on its own GFP-CLASP1a
also reduced MT growth rates, and it virtually eliminated MT ca-
tastrophes while increasing rescue frequency (Figure 2E). Thus,
consistent with cellular data [28], CLASPs stabilizeMT growth by
acting both as anti-catastrophe and rescue factors. However,
while CLASP2g only exerts its function in the presence of EB pro-
teins, the tubulin-binding TOGL1-domain allows CLASP1a to
promote continuous MT growth in an autonomous fashion.
These data suggest that CLASP isoforms use different mecha-
nisms to stimulate MT growth.
Stable Tubulin-TAP Interactions Are Required for
Efficient MT Nucleation and Growth
Mutations that give rise to tubulinopathies are thought to perturb
neuronal migration and differentiation because of defective
tubulin dimer formation, hampered MT dynamics, and/or
reduced binding of MAPs to MTs [29–31]. However, our finding
that mutant tubulins interact less well with a selected number
of TAPs suggested that MT-based processes that depend on
these TAPs might also be perturbed in tubulinopathy patients.
We therefore examined the intracellular behavior of the P263T
and R402H mutants in more detail.
We first confirmed that wild-type andmutant GFP-tubulins are
expressed at similar levels in RPE1 cells (Figure S4A). We then
examined live RPE1 cells, and we observed fluorescent MT net-
works less frequently in cells expressing mutant tubulins (Fig-
ure S4B). These mutants appeared to be assembly competent,
as we detectedMTs in virtually all cells after the addition of pacli-
taxel, a MT-stabilizing agent (Figure S4B). However, the fluores-
cence intensity of mutant MTswas less than that of MTs contain-
ing GFP-tagged wild-type tubulin (Figure S4C), suggesting that
mutant tubulins incorporate less efficiently into MTs. To examine
GFP-tubulin properties in more detail, we turned to fixed cells.
C
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A Figure 2. Regulation of MT Behavior by
CLASP Isoforms
(A) Schematic outline of CLASP isoforms and
tubulin pull-down experiment. The positions of
three TOGL domains (1–3) and the serine-rich EB-
binding region (gray rectangle) are indicated. HEK
cells expressing bio-Sumo*-GFP-tubulin and the
indicated YFP-tagged proteins were lysed, and
the interaction of the YFP-tagged proteins with
tubulin was examined by streptavidin-based
pull-down using anti-GFP antibodies. Molecular
weights ofmarker proteins are indicated to the left.
(B) Purification of GFP-CLASP1a and GFP-
CLASP2g. HEK cells expressing bio-Sumo*-GFP-
CLASP1a or bio-Sumo*-GFP-CLASP2g were
lysed, and fusion proteins were purified using
streptavidin beads. GFP-tagged proteins were
cleaved off the beads using Sumo* protease and
checked for purity on Coomassie-stained gels. M,
marker lane (molecular weights are indicated to
the left).
(C) TIRF microscopy images and kymographs of
MTs grown in the presence of GFP-CLASP1a only
(top), GFP-CLASP1a plus EB3 (middle), or GFP-
CLASP2g plus EB3 (bottom). Arrows indicate ex-
amples of MT plus-end-bound CLASPs.
(D) Fluorescence intensity profiles of GFP-
CLASP1a in the presence or absence of EB3, of
GFP-CLASP2g in the presence of EB3, and of
GFP-EB3 itself. The profiles represent the
normalized distribution of the various fluorescent
proteins on MT ends. The MT lattice is toward
the left.
(E) Parameters of dynamic MT behavior. Experi-
ments were performed in the presence of 15 mM
tubulin, 75 nM EB3, and 38 nM CLASPs. MT
growth and shrinkage rates are shown ±SD. Fc,
catastrophe frequency; Fr, rescue frequency; N,
number of MTs measured. Note that MT behavior
in the absence of +TIPs is similar to previous data
(e.g., [24, 25]; see also Figure 1G). Furthermore, as
reported (e.g., [24, 26]), we found that addition of
EB3 accelerated MT growth rate and enhanced
the frequencies of catastrophes and rescues of
in vitro polymerizing MTs.
See also Figure S3.
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Control experiments indicated that a quick pre-extraction of cells
prior to fixation removes soluble GFP signal without affecting the
MT network (Figure S4D). To measure the level of MT-bound
GFP-tubulin, we therefore analyzed fluorescence in cells that
were first pre-extracted and then fixed with paraformaldehyde.
To measure the total amount of GFP-tubulin (i.e., soluble and
MT bound), we examined cells that were fixed in paraformalde-
hyde without pre-extraction. We found that 34% of GFP-tubulin
was in MTs in cells cultured under normal conditions (Figure 3A,
left). By contrast, in cells treated with paclitaxel, 75% of GFP-
tubulin was MT bound (Figure 3A, right), suggesting that 75%
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Figure 3. Defects in MT-Based Processes
in Cells Expressing Mutant Tubulins
(A) MT incorporation of wild-type GFP-tubulin.
Transfected HEK293T cells were either treated
with paclitaxel for 2 hr (+ taxol) or not treated
( taxol) and were then either pre-extracted for
1 min and fixed with paraformaldehyde (WT Pr) or
only fixed with paraformaldehyde (WT PFA). The
fluorescence intensity (FI) of the whole cell was
measured in a.u. In the WT Pr sample, in which
soluble tubullin is washed away, the FI reflects the
amount of GFP-tubulin incorporated into MTs; in
the WT PFA sample, the FI reflects both soluble
and MT-bound GFP-tubulin.
(B and C) Efficiency of MT incorporation of wild-
type and mutant GFP-tubulins. HEK293T cells
were transfected with wild-type (WT) or mutant
(P263T and R402H) GFP-tubulin and were then
pre-extracted and fixed. After fixation, cells were
stained with anti-tubulin antibodies. Images in (C)
show insets of cells shown in Figure S4E. Using
a-tubulin staining, MT segments were outlined
(stippled lines show examples, placed adjacent to
the corresponding MTs), and the FI of the GFP
signal on the MT was measured in a.u. Quantifi-
cations are shown in (B).
(A and B) Data are shown ±SD, and t tests
were done to examine significance of differences
(*p < 0.05, ***p < 0.0001).
(D–F) MT re-growth in cells after nocodazole
washout. RPE1 cells were transfected with wild-
type (WT) or mutant (P263T and R402H) GFP-
tubulin. After 1 day, cells were treated for 2 hr with
2.5 mg/ml nocodazole and fixed at the indicated
times after washout (D, 0 min; E, 7 min; F, 30 min).
Cells were stained with either anti-a-tubulin or
anti-g-tubulin antibodies (red) to mark MTs or
centrosomes, respectively, and with anti-GM130
antibodies (cyan) to mark the Golgi. Yellow arrows
indicate examples of non-centrosomal Golgi-
derived MTs. Scale bar, 5 mm.
(G) Quantification of the number of cells with GFP-
tubulin incorporated into non-centrosomal MTs
(left), or with number of non-centrosomal MTs
per cell (right). Data are shown ±SEM, and t tests
were done to examine significance of differences
(***p < 0.0001).
See also Figure S4.
of wild-type GFP-tubulin is assembly
competent. This result is consistent with
our MT pelleting result in Figure 1E.
We next compared the capacity of wild-type and mutant tu-
bulins to incorporate into MTs by measuring fluorescence inten-
sities of MT segments in pre-extracted, fixed cells (Figure 3B;
note that MTs were outlined with the help of anti-tubulin anti-
bodies, see Figure 3C). In cells cultured under normal condi-
tions, the mutant tubulins incorporated less efficiently into
MTs as compared to the wild-type (Figures 3B, 3C, and S4E),
in line with results in live RPE1 cells (Figure S4C). Strikingly,
in paclitaxel-treated cells, the mutants incorporated better
than wild-type tubulin (Figures 3B, 3C, and S4E). These data
strongly suggest that mutant tubulins are fully assembly
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competent, raising the question of why they do not incorporate
efficiently into MTs under normal conditions. We propose that
the reduced binding of mutant tubulins to CLASPs and
CKAP5 (Figure S2C) contributes to their reduced incorporation
into MT ends. We furthermore note that the improved incorpo-
ration of mutant tubulins after paclitaxel treatment opens per-
spectives for treatment of tubulinopathy patients, not with
paclitaxel, as this compound does not pass the blood-brain
barrier, but perhaps with epothilone B, a MT-stabilizing agent
that does [32].
Tubulin dimers have an intrinsic capacity to self-organize into
MTs in a process known as MT nucleation. However, the kinetic
barrier is high, meaning that the efficiency with which MTs spon-
taneously nucleate is very low. In cells MT nucleation therefore
occurs in MT -organizing centers (MTOCs), of which the centro-
some is the major one. However, non-centrosomal MT nucle-
ation, for example at the Golgi apparatus, is also common in
cells. As Golgi-mediated MT nucleation depends on GCC185
and the CLASPs [5] and mutant tubulins bind these proteins
less efficiently, we investigated whether expression of the
mutants affects this process. We treated RPE1 cells with
nocodazole, a MT-depolymerizing agent, and first examined
incorporation of GFP-tubulin at the centrosome and Golgi after
nocodazole washout. Nocodazole treatment almost completely
abolished theMT network and caused dispersal of theGolgi (Fig-
ure 3D). Sevenminutes after washout, GFP-labeled centrosomal
and non-centrosomal MTs were detected in cells transfected
with wild-type tubulin, but in cells expressing TUBA1A-P263T
or TUBA1A-R402H we did not observe any incorporation of
mutant tubulin into regrowing MTs (Figure 3E; see also quantifi-
cation in Figure 3G). By contrast, 30 min after washout, we did
observe MTs with fluorescent TUBA1A-P263T or TUBA1A-
R402H (Figure 3F).
To examine re-growth of the complete MT network, we
stained cells with anti-a-tubulin. This revealed that MTs do
form early on after washout (Figure 3E). Interestingly, although
the mutant tubulins themselves did not incorporate into Golgi-
derived MTs at early time points, their presence did hamper for-
mation of these MTs (Figure 3G). MT nucleation at the Golgi has
been suggested to proceed in a step-wise fashion, with GCC185
providing a Golgi-based docking platform for the CLASPs and
the CLASPs in turn stimulating MT growth by binding nascent
MTs [5]. Our in vitro results support the idea that CLASPs pro-
mote MT growth. However, GCC185 also binds tubulin; in fact,
like the CLASPs, GCC185 is one of the prominent TAPs identified
in this study (Tables 1 and S1). As mutant tubulins bind less effi-
ciently to CLASPs andGCC185 and expression of thesemutants
hampers Golgi-mediatedMT nucleation in cells, we propose that
tubulin-CLASP, tubulin-GCC185, and CLASP-GCC185 interac-
tions are all important for setting up a platform at the Golgi for
efficient MT nucleation.
Finally, since mutant tubulins also interacted less efficiently
with TAPs that are important for cilia formation, we tested
whether ciliogenesis is affected in RPE1 cells expressing the
mutants. We found that the percentage of RPE1 cells with cilia
was reduced upon expression of both mutants; in addition,
TUBA1A-R402H expression affected ciliary length (Figures S4F
and S4G). We conclude that mutant tubulins hamper both cilio-
genesis and non-centrosomal MT nucleation. The P263T and
R402H mutants may affect these processes by competing with
normal tubulin for TAPs. It is noteworthy that Golgi-mediated
MT nucleation contributes to directed cell motility [33] and that
cilia are important for directed neuronal migration [34]. Thus,
reduced tubulin-TAP interactions may cause neuronal migration
problems in tubulinopathy patients due to defective cilia and
Golgi-based MT nucleation. Together, our data widen the spec-
trum of MT-mediated processes that are deregulated in the
tubulinopathies.
Conclusions
We have developed an approach to express and purify func-
tional mammalian tubulin dimers from transiently transfected
cells. We used this method to identify TAPs in cultured
HEK293T cells. This ‘‘tubulome,’’ which contains many novel
factors, includes CKAP5 and the CLASPs, which are MT plus-
end-tracking proteins with multiple TOG(L)-domains, and
GCC185, a Golgi-associated protein that binds CLASPs. We
show that the N-terminal TOGL1 domain is required for efficient
tubulin binding by CLASP1 and allows CLASP1 to promote MT
growth in an autonomous manner. Furthermore, two mutant tu-
bulins, known to cause brain malformation and neuronal differ-
entiation defects in tubulinopathy patients, bind less efficiently
to certain TAPs, incorporate less well into MTs, and impair intra-
cellular processes involving TAPs. Thus, stable tubulin-TAP
interactions, which are perturbed by tubulin mutations, are
required for efficient MT nucleation and growth. Our results
provide a resource for investigating tubulin interactions and
functions and widen the spectrum of tubulin-related disease
mechanisms.
ACCESSION NUMBERS
The protein interactions from this publication have been submitted to the IMEx
(http://www.imexconsortium.org) consortium through IntAct [35] and assigned
the identifier IM-25115.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, one table, and one movie and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2016.04.069.
AUTHOR CONTRIBUTIONS
All authors designed and performed subsets of experiments, analyzed data
belonging to those experiments, and helped to write the paper. N.G.
conceived and supervised the project.
ACKNOWLEDGMENTS
We thank Dave Lammers for preparing the Bio-Sumo*-GFP-CLASP con-
structs. This work was supported by Netherlands Organization for Scientific
Research (NWO) Chemical Sciences (700.59.011) and Graduate Program
(022.004.002) grants. This work is also part of the project Proteins At Work,
a program of The Netherlands Proteomics Centre financed by the NWO as
part of the National Roadmap Large-Scale Research Facilities of the
Netherlands (project number 184.032.201).
Received: January 21, 2015
Revised: March 15, 2016
Accepted: April 26, 2016
Published: June 9, 2016
Current Biology 26, 1728–1736, July 11, 2016 1735
59
Chapter 2
REFERENCES
1. de Forges, H., Bouissou, A., and Perez, F. (2012). Interplay betweenmicro-
tubule dynamics and intracellular organization. Int. J. Biochem. Cell Biol.
44, 266–274.
2. Kapitein, L.C., and Hoogenraad, C.C. (2015). Building the neuronal micro-
tubule cytoskeleton. Neuron 87, 492–506.
3. Breuss, M., and Keays, D.A. (2014). Microtubules and neurodevelopmen-
tal disease: the movers and the makers. Adv. Exp. Med. Biol. 800, 75–96.
4. Al-Bassam, J., and Chang, F. (2011). Regulation of microtubule dynamics
by TOG-domain proteins XMAP215/Dis1 and CLASP. Trends Cell Biol. 21,
604–614.
5. Efimov, A., Kharitonov, A., Efimova, N., Loncarek, J., Miller, P.M.,
Andreyeva, N., Gleeson, P., Galjart, N., Maia, A.R., McLeod, I.X., et al.
(2007). Asymmetric CLASP-dependent nucleation of noncentrosomal
microtubules at the trans-Golgi network. Dev. Cell 12, 917–930.
6. Desai, A., and Mitchison, T.J. (1997). Microtubule polymerization dy-
namics. Annu. Rev. Cell Dev. Biol. 13, 83–117.
7. Miller, H.P., and Wilson, L. (2010). Preparation of microtubule protein and
purified tubulin from bovine brain by cycles of assembly and disassembly
and phosphocellulose chromatography. Methods Cell Biol. 95, 3–15.
8. Luduen˜a, R.F. (1998). Multiple forms of tubulin: different gene products
and covalent modifications. Int. Rev. Cytol. 178, 207–275.
9. Tian, G., Huang, Y., Rommelaere, H., Vandekerckhove, J., Ampe, C., and
Cowan, N.J. (1996). Pathway leading to correctly folded beta-tubulin. Cell
86, 287–296.
10. Minoura, I., Hachikubo, Y., Yamakita, Y., Takazaki, H., Ayukawa, R.,
Uchimura, S., and Muto, E. (2013). Overexpression, purification, and
functional analysis of recombinant human tubulin dimer. FEBS Lett. 587,
3450–3455.
11. Kim, J.H., Lee, S.-R., Li, L.-H., Park, H.-J., Park, J.-H., Lee, K.Y., Kim,
M.-K., Shin, B.A., and Choi, S.-Y. (2011). High cleavage efficiency of
a 2A peptide derived from porcine teschovirus-1 in human cell lines,
zebrafish and mice. PLoS ONE 6, e18556.
12. Bieling, P., Laan, L., Schek, H., Munteanu, E.L., Sandblad, L., Dogterom,
M., Brunner, D., and Surrey, T. (2007). Reconstitution of a microtubule
plus-end tracking system in vitro. Nature 450, 1100–1105.
13. Bahi-Buisson,N., Poirier,K., Fourniol, F., Saillour,Y., Valence,S., Lebrun,N.,
Hully, M., Bianco, C.F., Boddaert, N., Elie, C., et al.; LIS-Tubulinopathies
Consortium (2014). The wide spectrum of tubulinopathies: what are the
key features for the diagnosis? Brain 137, 1676–1700.
14. Tian, G., Jaglin, X.H., Keays, D.A., Francis, F., Chelly, J., and Cowan, N.J.
(2010). Disease-associated mutations in TUBA1A result in a spectrum of
defects in the tubulin folding and heterodimer assembly pathway. Hum.
Mol. Genet. 19, 3599–3613.
15. Janke, C. (2014). The tubulin code: molecular components, readout mech-
anisms, and functions. J. Cell Biol. 206, 461–472.
16. Chuong, S.D., Good, A.G., Taylor, G.J., Freeman, M.C., Moorhead, G.B.,
and Muench, D.G. (2004). Large-scale identification of tubulin-binding
proteins provides insight on subcellular trafficking, metabolic channeling,
and signaling in plant cells. Mol. Cell. Proteomics 3, 970–983.
17. Gache, V., Louwagie, M., Garin, J., Caudron, N., Lafanechere, L., and
Valiron, O. (2005). Identification of proteins binding the native tubulin
dimer. Biochem. Biophys. Res. Commun. 327, 35–42.
18. Honnappa, S., Gouveia, S.M., Weisbrich, A., Damberger, F.F., Bhavesh,
N.S., Jawhari, H., Grigoriev, I., van Rijssel, F.J., Buey, R.M., Lawera, A.,
et al. (2009). An EB1-binding motif acts as a microtubule tip localization
signal. Cell 138, 366–376.
19. Spektor, A., Tsang, W.Y., Khoo, D., and Dynlacht, B.D. (2007). Cep97 and
CP110 suppress a cilia assembly program. Cell 130, 678–690.
20. Akhmanova, A., Hoogenraad, C.C., Drabek, K., Stepanova, T., Dortland,
B., Verkerk, T., Vermeulen, W., Burgering, B.M., De Zeeuw, C.I.,
Grosveld, F., and Galjart, N. (2001). Clasps are CLIP-115 and -170 asso-
ciating proteins involved in the regional regulation of microtubule dy-
namics in motile fibroblasts. Cell 104, 923–935.
21. van der Vaart, B., Manatschal, C., Grigoriev, I., Olieric, V., Gouveia, S.M.,
Bjelic, S., Demmers, J., Vorobjev, I., Hoogenraad, C.C., Steinmetz, M.O.,
and Akhmanova, A. (2011). SLAIN2 links microtubule plus end-tracking
proteins and controls microtubule growth in interphase. J. Cell Biol. 193,
1083–1099.
22. Brouhard, G.J., Stear, J.H., Noetzel, T.L., Al-Bassam, J., Kinoshita, K.,
Harrison, S.C., Howard, J., and Hyman, A.A. (2008). XMAP215 is a proc-
essive microtubule polymerase. Cell 132, 79–88.
23. Al-Bassam, J., Kim, H., Brouhard, G., van Oijen, A., Harrison, S.C., and
Chang, F. (2010). CLASP promotes microtubule rescue by recruiting
tubulin dimers to the microtubule. Dev. Cell 19, 245–258.
24. Montenegro Gouveia, S., Leslie, K., Kapitein, L.C., Buey, R.M., Grigoriev,
I., Wagenbach, M., Smal, I., Meijering, E., Hoogenraad, C.C., Wordeman,
L., et al. (2010). In vitro reconstitution of the functional interplay between
MCAK and EB3 at microtubule plus ends. Curr. Biol. 20, 1717–1722.
25. Odde, D.J., Cassimeris, L., and Buettner, H.M. (1995). Kinetics of micro-
tubule catastrophe assessed by probabilistic analysis. Biophys. J. 69,
796–802.
26. Maurer, S.P., Cade, N.I., Bohner, G., Gustafsson, N., Boutant, E., and
Surrey, T. (2014). EB1 accelerates two conformational transitions impor-
tant for microtubule maturation and dynamics. Curr. Biol. 24, 372–384.
27. Maki, T., Grimaldi, A.D., Fuchigami, S., Kaverina, I., and Hayashi, I. (2015).
CLASP2 has two distinct TOGdomains that contribute differently tomicro-
tubule dynamics. J. Mol. Biol. 427, 2379–2395.
28. Mimori-Kiyosue, Y., Grigoriev, I., Lansbergen, G., Sasaki, H., Matsui, C.,
Severin, F., Galjart, N., Grosveld, F., Vorobjev, I., Tsukita, S., and
Akhmanova, A. (2005). CLASP1 and CLASP2 bind to EB1 and regulate
microtubule plus-end dynamics at the cell cortex. J. Cell Biol. 168,
141–153.
29. Tian, G., Kong, X.P., Jaglin, X.H., Chelly, J., Keays, D., and Cowan, N.J.
(2008). A pachygyria-causing alpha-tubulin mutation results in inefficient
cycling with CCT and a deficient interaction with TBCB. Mol. Biol. Cell
19, 1152–1161.
30. Niwa, S., Takahashi, H., and Hirokawa, N. (2013). b-Tubulin mutations
that cause severe neuropathies disrupt axonal transport. EMBO J. 32,
1352–1364.
31. Tischfield, M.A., Baris, H.N., Wu, C., Rudolph, G., Van Maldergem, L., He,
W., Chan, W.-M., Andrews, C., Demer, J.L., Robertson, R.L., et al. (2010).
Human TUBB3 mutations perturb microtubule dynamics, kinesin interac-
tions, and axon guidance. Cell 140, 74–87.
32. Ruschel, J., Hellal, F., Flynn, K.C., Dupraz, S., Elliott, D.A., Tedeschi, A.,
Bates, M., Sliwinski, C., Brook, G., Dobrindt, K., et al. (2015). Axonal
regeneration. Systemic administration of epothilone B promotes axon
regeneration after spinal cord injury. Science 348, 347–352.
33. Miller, P.M., Folkmann, A.W., Maia, A.R., Efimova, N., Efimov, A., and
Kaverina, I. (2009). Golgi-derived CLASP-dependent microtubules control
Golgi organization and polarized trafficking in motile cells. Nat. Cell Biol.
11, 1069–1080.
34. Me´tin, C., and Pedraza, M. (2014). Cilia: traffic directors along the road of
cortical development. Neuroscientist 20, 468–482.
35. Orchard, S., Ammari, M., Aranda, B., Breuza, L., Briganti, L., Broackes-
Carter, F., Campbell, N.H., Chavali, G., Chen, C., del-Toro, N., et al.
(2014). The MIntAct project–IntAct as a common curation platform for 11
molecular interaction databases. Nucleic Acids Res. 42, D358–D363.
1736 Current Biology 26, 1728–1736, July 11, 2016
60
For copyright reasons 
chapters 3,4 and 5 are 
still under embargo
α-Tubulin mutations causing brain malformations investigated by all-atom 
molecular dynamics simulations
Luca Signorile†, Kris Leslie‡, Niels Galjart†1
† Department of Cell Biology, Erasmus Medical Center Faculty Building, PO Box 2040, 3000CA 
Rotterdam, the Netherlands. 
1 Corresponding author. E-mail: n.galjart@erasmusmc.nl
‡ Present address: School of Human and Life Sciences, Canterbury Christ Church University, North 
Holmes Road, Canterbury, Kent CT1 1QU, United Kingdom.
Manuscript in preparation
Chapter 3
 
Chapter 4
 
CLIPs regulate microtubule, centrosome and ciliary behavior by linking protein 
complexes to specifi c conformations of tyrosinated tubulin
Luca Signorile1, Marja Miedema1, Sreya Basu1, Malgorzata Grosbart2, Nuo Yu1, Sophie 
Ottema1, Yulia Komarova1, Jeffrey van Haren1, Michael Olvedy1, Ihor Smal3, Nanda Keijzer1, 
Dick Dekkers4, Isabelle Arnal5, Claire Wyman2, Jeroen Demmers4, Frank Grosveld1, Niels 
Galjart#1.
1) Department of Cell Biology, Erasmus Medical Center Faculty   Building, PO Box 2040, 3000CA 
Rotterdam, The Netherlands.
2) Department of Molecular Genetics, Erasmus Medical Center Faculty Building, PO Box 2040, 3000CA 
Rotterdam, The Netherlands.
3) Biomedical Imaging Group Rotterdam, Erasmus Medical Center, 3015 GE, Rotterdam, 
The Netherlands.
4) Proteomics Centre, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
5) Grenoble Institute des Neurosciences, Grenoble, France
# Corresponding author. E-mail: n.galjart@erasmusmc.nl
Manuscript in preparation
Chapter 5 
General Discussion
Addendum
126
Curriculum vitae
PERSONAL DETAILS
Name    Luca Signorile
Date of birth   11 February 1986
Place of birth   Bari, Italy
EDUCATION 
2013-2017   PhD program at Erasmus Medical Center
    Department of Cell Biology, Erasmus Medical Center, 
    Rotterdam, The Netherlands 
2010-2012   Master of Science in Molecular Medicine
    Erasmus Medical Center, Rotterdam, The Netherlands
2006-2010   Bachelor of Science in Pharmaceutical and Health 
    Biotechnologies, University of Bari, Italy
2000-2005   Scientific High School “A. Scacchi”, Bari, Italy
RESEARCH
2013-2017   PhD research
    Department of Cell Biology, Erasmus MC, Rotterdam, 
    The Netherlands  (Prof.dr. D. Huylebroeck, Prof.dr. F.G.   
    Grosveld and Dr.ir. N.J. Galjart)
2011-2012   MSc research project
    Department of Cell Biology, Erasmus MC, Rotterdam, The  
    Netherlands (Dr. R.A. Poot)
2011    MSc research project
    Department of Orthopaedics and Otorhinolaringology,   
    Erasmus MC, Rotterdam, The Netherlands (Dr. R. Narcisi  
    and Prof.dr. G.J.V.M. van Osch) 
127
Addendum
Publications
 
“Isolation of Functional Tubulin Dimers and of Tubulin-Associated Proteins from Mammalian 
Cells.” Yu N*, Signorile L*, Basu S, Ottema S, Lebbink JH, Leslie K, Smal I, Dekkers D, 
Demmers J, Galjart N. Curr Biol. 2016 Jul 11;26(13):1728-36. [* shared first author]
”ACTG2 variants impair actin polymerization in sporadic Megacystis Microcolon Intestinal 
Hypoperistalsis Syndrome.” Halim D, Hofstra RM, Signorile L, Verdijk RM, van der Werf CS, 
Sribudiani Y, Brouwer RW, van IJcken WF, Dahl N, Verheij JB, Baumann C, Kerner J, van 
Bever Y, Galjart N, Wijnen RM, Tibboel D, Burns AJ, Muller F, Brooks AS, Alves MM. Hum Mol 
Genet. 2016 Feb 1;25(3):571-83.  
“Proteins that bind regulatory regions identified by histone modification chromatin 
immunoprecipitations and mass spectrometry.” Engelen E, Brandsma JH, Moen MJ, Signorile 
L, Dekkers DH, Demmers J, Kockx CE, Ozgür Z, van IJcken WF, van den Berg DL, Poot RA. 
Nat Commun. 2015 May 20;6:7155. 
“TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation 
capacity of human articular chondrocytes.” Narcisi R, Signorile L, Verhaar JA, Giannoni P, 
van Osch GJ. Osteoarthritis Cartilage. 2012 Oct;20(10):1152-60.
128
PhD Portfolio
 
Name student   Luca Signorile
Erasmus MC Department  Cell Biology
Research school   Graduate School MGC
PhD period   March 2013-September 2017
Promoters   Danny Huylebroeck, Frank G. Grosveld
co-promoter   Niels J. Galjart
PhD training
Courses
2013    Basic Course on R (Rotterdam)
2013    Genetics (Rotterdam)
2013    Safely working in the laboratory (Leiden)
2013    Biochemistry and Biophysics (Rotterdam)
2014    Microscopic Image Analysis (Rotterdam)
2014    Cell and Developmental Biology (Rotterdam)
2014    Biostatistical Methods (Rotterdam)
2015    Scientific Integrity (Rotterdam)
2015    Linux and Basic Scripting Course (Leiden) 
2016    English Biomedical Writing (Rotterdam) 
 
Workshops, Symposia and Conferences
2017    27th MGC symposium, Rotterdam, The Netherlands (oral presentation)
2017    1st Meeting ACE Systems Biomedicine, Rotterdam, The Netherlands
2013-2017   Department Meetings
2013    20th MGC PhD workshop, Luxembourg, Luxembourg
2013    23rd MGC Symposium, Rotterdam, The Netherlands 
2014    EMBO conference: Microtubules: Structure, regulation and functions, Hei 
    delberg, Germany (poster presentation)
2014    21st MGC PhD workshop, Münster, Germany (poster presentation)
2014    24th MGC Symposium, Rotterdam, The Netherlands 
2015    22nd MGC PhD workshop, Maastricht, The Netherlands (oral presentation)
2015    25th MGC Symposium, Leiden, The Netherlands
2016    23rd MGC PhD workshop, Dortmund, Germany (oral presentation)
2016    2nd European Meeting of Neuroscience for PhD students, Grenoble   
    Institute of Neuroscience, France (oral presentation)
Teaching activities 
2014    BSc Nanobiology Program, supervision of 2 students
2015-2016   BSc student supervision
2015    Teaching assistant for Protein Structure Course for BSc Nanobiology   
    Program (Rotterdam)
2017    Teaching assistant for Protein Structure Course for PhD Program 
    (Rotterdam)
Additional Activities
2013-2017   Department Server Administrator
129
Addendum
Acknowledgements
First of all, I would like to express my gratitude to my promoters, Danny and Frank. Danny, 
thanks for your critical insight and helpful comments not only for this thesis, but also throughout 
my PhD. You had always time for me even in the most hectic moments, thank you. Frank, thank 
you for all the advice you gave me during these years, and thank you for the nice discussions 
about cell biology, biochemistry, chemistry and physics! Niels, it seems like yesterday we first 
had our first chat about microtubules: I still cannot believe 4 years have passed since then. 
Thank you for your guidance, your openness to new ideas, your positive and encouraging 
attitude (also when I was frustrated because of failed experiments!) and for your support and 
understanding. I have learned a lot from you, thank you. Gert, Marileen, Isabelle, Joyce and 
Kris: I could have not asked for better committee members; thank you for being part of it! 
Isabelle, I still have great memories from the time I visited your lab two years ago, thank you 
so much for your time and help!  Joyce, I was very happy when you asked me if I could help 
you out with the Protein Structure course. I enjoyed it and I learned a lot from your teaching, as 
well as when we were talking about structural studies and biochemistry, and when you taught 
me how to perform gel filtration and surface plasmon experiments. Thank you very much for 
all your help! Kris, although you left the group shortly after I had started my PhD, you have 
been of great help, supportive and a great teacher. It is to you that I mainly owe my passion for 
structural biology, molecular modeling and molecular dynamics studies (let’s discuss another 
time about quantum mechanics, better with a couple of pints of ale!). Ihor: thank you very 
much for the custom-made plugin you made for MT dynamics parameters! And of course for 
all your help on image processing, analysis, R, statistics, Linux tips, etc.! I think I am forgetting 
more things, but I thank you also for them! Best of luck for your career!! Maarten, thanks 
for your prompt help with R. A big thank you to the whole Optical Imaging Center! Special 
thanks to Martijn for all the help and training on the TIRF, and for being always so patient and 
kind whenever I bothered him! 
 Marike, thank you so much for all the help, especially towards the defence! You are 
great! To my friends and paranymphs Andrea, Martì and Enrico: I cannot say how much I 
am grateful for your (practical and psychological) support and how much I enjoyed the great 
times we had, not only during these last crazy months of my PhD, but during all these years. 
I was really lucky having you beside me, thank you! (Andrea, grazie ancora per il “supporto 
logistico” al mio trentesimo compleanno: e chi se lo scorda? Enrico, daje, manca poco anche 
a te!! Martì, you are very close to finishing as well: best of luck to you and Marta!!) Claire, thank 
you for your collaboration, your availability, for the input you provided and for the stimulating 
conversations. SFM is cool! And of course Gosia, lots of good luck for your future! Thanks for 
all the work you have done for the SFM included in Chapter 4. Lena, “the TIRFer”, first of all a 
huge thank you for designing the magnificent cover of this thesis!! I am so happy I asked you 
(who knows what could have been of it, otherwise!!). Best of luck for your future, please let’s 
keep in touch! I will miss our weekend drinks and conversations about Tool! To the present 
and past members of Lab1030: Sreya, thank you for the nice chats and support during our late 
hours at work, and thanks also for your patience and the help in the lab; good luck with your 
career! Nuo, it has been great working with you, especially for the paper we co-authored. And 
keep on smiling as you always do! Best of luck to you and Oliver. Sophie, I will never forget 
the good times in the lab and in Heidelberg! Katja, Yannicka, Arie, Enzo and Mingkun: good 
luck! Kerstin, thanks for your help and advice not only for work-related matters, but also for 
my future: thank you! Raymond and Erik, it is in your lab that I learned a lot of biochemistry 
and molecular biology techniques: thank you. 
130
 A big thank you to the band The Microtubules! Marti, Enrico, Lennart: you see? I 
have said it! Guys, thanks a lot for the great fun during our rehearsals and during the post-
rehearsals beers and hamburgers!  Aristea, thank you so much for your help, best of luck 
in Sweden!! Sarra, good luck for your future, but try to work a bit less... Irene, Judith, Lize, 
Ilias, Pablo, Rodrigo, Jente: thank you for the fun times and good luck with your PhDs, you 
will do great! Eskeww, it is great to see you again in the EMC! I am passing on to you the 
responsibility of Kolossus: treat it well! 
 To the whole Cell Biology Department and in particular to Mieke, Ser, Sylvia, Martjin 
(thanks for the help with the layout of the last days and, of course, for the ultracentrifuge 
tubes!), Evelien: keep up with the fun borrels and parties (and good science!). Rick, the first 
and only Dutch man to prefer wine and gin over beer: it has been nice sharing some enological 
thoughts with you (besides scientific ones, of course)! Mateusz, good luck in finishing your 
PhD! The “IT team”: Toon, Nils, and especially Sjozef: thank you so much for helping me out 
with server matters and Linux issues (sorry for having hassled you so much Sjozef! I learned 
a lot from you). Johannes, Cristina, Yasemin and Mariangela: such crazy days at the PhD 
workshops! Hang in there for a bit more, you are very close to finishing!  
 And now, the “Italian gang”: Isa (per favore, sii meno gentile e disponibile col prossimo! 
Scherzo...non cambiare, sei una persona squisita!! Ricordo ancora che sei stata la prima 
persona che ho conosciuto a Rotterdam...In bocca al lupo per tutto e grazie ancora per gli 
splendidi giorni a Chiavenna), Jessica (grazie per tutte le risate, le cene, i consigli  lavorativi 
e di shopping, l’aiuto con il forno sotto il diluvio, etc... ed ovviamente per  essermi sempre 
stata accanto anche nei momenti più difficili. In bocca al lupo per tutto!!!), Thomas (lots of 
good luck for your future man! Hope to visit you soon!), Chris (sooner or later I will make it to 
Edinburgh! And yes, you are Italian!), Jovana ed Enrico (un ultimo sforzo, ci siete quasi! Mi 
prenoto giá per venire a Meolo e per fare una ferrata sulle Dolomiti!), Flavia e Simone (grazie 
per tutte le risate e i manicaretti! E chi se le scorda le magnate insieme?), Marta (ci vediamo a 
Stoccolma! Sono sicuro ti troverai bene), e poi Federica, Ale, Agnese, Friedemann, Fabrizia 
e Hegias (in bocca al lupo a tutti voi!). Chiara e Domenico (sono stato davvero contento di 
avervi incontrato! In bocca al lupo!), Alessia (come non ricordare i mercoledí sera al Bird in 
compagnia di Enrico e degli infiniti giri di Maredsous! Per non parlare del pranzo di Pasqua...
Ci vediamo a Bologna!) e Sabrina (in bocca al lupo per il tuo futuro, nella vita lavorativa e 
non solo!). Adela, moltes gràcies per tindre tanta paciencia amb mi durant aquests últims i 
estresants mesos, i moltes gràcies per tots els bons moments i riures que hem tingut junts en 
totes les circumstàncies! Et desitge el millor, tinc moltes ganes de veure’t de nou prompte! 
 Marco, Giovanni e Alessandro, amici storici, anzi fratelli. Ho così tanti ricordi che 
non saprei da dove iniziare. Siete grandi e sappiate che ci sono sempre per voi. Davvero 
non posso esprimere la mia riconoscenza per essermi stati vicini da subito così come i vostri 
genitori (Daniela, Emanuele, Gianna, Domenico, Antonietta e Gino: un grazie stragrande 
per avermi sempre accolto come un figlio), senza se e senza ma, e sempre pronti ad aiutarmi. 
Patrizia, quando andiamo in bosco? Grazie per essermi stata accanto. Un grazie a tutti i miei 
parenti. Clara, sei la donna piú forte e testarda che conosca: continua cosí! Ai miei zii teutonici 
Valentina e Hermann (vielen Dank für ihre Hilfe in diesen Jahren!) e a quelli meno teutonici 
Mirella e Mimmo: grazie mille per tutto quello che avete fatto per me, soprattutto da quando 
avevo 15 anni. Non lo scorderò mai ed è in gran parte merito vostro se ho raggiunto questo 
traguardo. Siete un esempio per me. Grazie, grazie, grazie.
